<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65712</article-id><article-id pub-id-type="doi">10.7554/eLife.65712</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group> <article-title>Sushi domain-containing protein 4 controls synaptic plasticity and motor learning</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-219753"><name> <surname>González-Calvo</surname><given-names>Inés</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2652-2160</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-219754"><name><surname>Iyer</surname><given-names>Keerthana</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4384-6781</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219755"><name><surname>Carquin</surname><given-names>Mélanie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219756"><name><surname>Khayachi</surname><given-names>Anouar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219757"><name><surname>Giuliani</surname><given-names>Fernando A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219760"><name><surname>Sigoillot</surname><given-names>Séverine M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219758"><name><surname>Vincent</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219759"><name><surname>Séveno</surname><given-names>Martial</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219761"><name><surname>Veleanu</surname><given-names>Maxime</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219762"><name><surname>Tahraoui</surname><given-names>Sylvana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219763"><name><surname>Albert</surname><given-names>Mélanie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219764"><name><surname>Vigy</surname><given-names>Oana</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219768"><name><surname>Bosso-Lefèvre</surname><given-names>Célia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219765"><name><surname>Nadjar</surname><given-names>Yann</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219766"><name><surname>Dumoulin</surname><given-names>Andréa</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146349"><name><surname>Triller</surname><given-names>Antoine</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71643"><name><surname>Bessereau</surname><given-names>Jean-Louis</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3088-7621</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-63456"><name><surname>Rondi-Reig</surname><given-names>Laure</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1006-0501</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219767"><name><surname>Isope</surname><given-names>Philippe</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0630-5935</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-137752"><name><surname>Selimi</surname><given-names>Fekrije</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7704-5897</contrib-id><email>fekrije.selimi@college-de-france.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution>Institut des Neurosciences Cellulaires et Intégratives (INCI), CNRS, Université de Strasbourg</institution><addr-line><named-content content-type="city">Strasbourg</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution>Institut Biology Paris Seine (IBPS), Neuroscience Paris Seine (NPS), CeZaMe, CNRS, Sorbonne University, INSERM</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff4"><label>4</label><institution>BioCampus Montpellier, CNRS, INSERM, Université de Montpellier</institution><addr-line><named-content content-type="city">Montpellier</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution>Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier</institution><addr-line><named-content content-type="city">Montpellier</named-content></addr-line><country>France</country></aff><aff id="aff6"><label>6</label><institution>École Normale Supérieure, Institut de Biologie de l'ENS, INSERM, CNRS, PSL Research University</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff7"><label>7</label><institution>Université de Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U 1217, Institut Neuromyogène</institution><addr-line><named-content content-type="city">Lyon</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Carey</surname><given-names>Megan R</given-names></name><role>Reviewing Editor</role><aff><institution>Champalimaud Foundation</institution><country>Portugal</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Westbrook</surname><given-names>Gary L</given-names></name><role>Senior Editor</role><aff><institution>Oregon Health and Science University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, UMR 5297, F-33000, Bordeaux, France</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>04</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65712</elocation-id><history><date date-type="received" iso-8601-date="2020-12-13"><day>13</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-03-03"><day>03</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, González-Calvo et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>González-Calvo et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65712-v2.pdf"/><abstract><p>Fine control of protein stoichiometry at synapses underlies brain function and plasticity. How proteostasis is controlled independently for each type of synaptic protein in a synapse-specific and activity-dependent manner remains unclear. Here, we show that <italic>Susd4</italic>, a gene coding for a complement-related transmembrane protein, is expressed by many neuronal populations starting at the time of synapse formation. Constitutive loss-of-function of <italic>Susd4</italic> in the mouse impairs motor coordination adaptation and learning, prevents long-term depression at cerebellar synapses, and leads to misregulation of activity-dependent AMPA receptor subunit GluA2 degradation. We identified several proteins with known roles in the regulation of AMPA receptor turnover, in particular ubiquitin ligases of the NEDD4 subfamily, as SUSD4 binding partners. Our findings shed light on the potential role of <italic>SUSD4</italic> mutations in neurodevelopmental diseases.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>synapse</kwd><kwd>plasticity</kwd><kwd>cerebellum</kwd><kwd>proteostasis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>ATIP-AVENIR</institution></institution-wrap></funding-source><award-id>RSE11005JSA</award-id><principal-award-recipient><name><surname>Selimi</surname><given-names>Fekrije</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Idex PSL</institution></institution-wrap></funding-source><award-id>ANR-10-IDEX-0001-02 PSL*</award-id><principal-award-recipient><name><surname>Selimi</surname><given-names>Fekrije</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR 9139SAMA90010901</award-id><principal-award-recipient><name><surname>Isope</surname><given-names>Philippe</given-names></name><name><surname>Selimi</surname><given-names>Fekrije</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-15-CE37-0001-01 CeMod</award-id><principal-award-recipient><name><surname>Isope</surname><given-names>Philippe</given-names></name><name><surname>Selimi</surname><given-names>Fekrije</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>DEQ20150331748</award-id><principal-award-recipient><name><surname>Selimi</surname><given-names>Fekrije</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>DEQ20140329514</award-id><principal-award-recipient><name><surname>Isope</surname><given-names>Philippe</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>SynID 724601</award-id><principal-award-recipient><name><surname>Selimi</surname><given-names>Fekrije</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>Labex Memolife</institution></institution-wrap></funding-source><award-id>ANR-10-LABX-54 MEMO LIFE</award-id><principal-award-recipient><name><surname>Iyer</surname><given-names>Keerthana</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>Ecole des Neurosciences de Paris</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Iyer</surname><given-names>Keerthana</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004100</institution-id><institution>Labex</institution></institution-wrap></funding-source><award-id>ANR-11-IDEX-0004-02</award-id><principal-award-recipient><name><surname>Rondi-Reig</surname><given-names>Laure</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>SUSD4 loss-of-function induces misregulation of GLUA2 degradation and of synaptic plasticity suggesting a mechanism for its potential contribution to neurodevelopmental disorders.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Proteostasis is at the core of many cellular processes and its dynamics need to be finely regulated for each protein in each organelle. In neurons, additional challenges are imposed by their spatial complexity. In particular, during long-term synaptic plasticity, the proposed substrate for learning and memory (<xref ref-type="bibr" rid="bib19">Collingridge et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Nicoll, 2017</xref>), the number of neurotransmitter receptors needs to be regulated independently in a synapse-specific and activity-dependent manner. At excitatory synapses, the modification of AMPA receptor numbers is a highly dynamic process, involving regulation of receptor diffusion (<xref ref-type="bibr" rid="bib15">Choquet and Triller, 2013</xref>; <xref ref-type="bibr" rid="bib68">Penn et al., 2017</xref>), their insertion in the plasma membrane, anchoring at the postsynaptic density and endocytosis (<xref ref-type="bibr" rid="bib1">Anggono and Huganir, 2012</xref>). After activity-dependent endocytosis, AMPA receptors are either recycled to the plasma membrane or targeted to the endolysosomal compartment for degradation (<xref ref-type="bibr" rid="bib27">Ehlers, 2000</xref>; <xref ref-type="bibr" rid="bib55">Lee et al., 2004</xref>; <xref ref-type="bibr" rid="bib67">Park et al., 2004</xref>). The decision between these two fates, recycling or degradation, regulates the direction of synaptic plasticity. Recycling promotes long-term potentiation (LTP) and relies on many molecules such as GRASP1, GRIP1, PICK1, and NSF (<xref ref-type="bibr" rid="bib1">Anggono and Huganir, 2012</xref>). Targeting to the endolysosomal compartment and degradation promote long-term depression (LTD; <xref ref-type="bibr" rid="bib29">Fernández-Monreal et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Matsuda et al., 2013</xref>), but the regulation of the targeting and degradation process remains poorly understood.</p><p>The Complement Control Protein (CCP) domain, an evolutionarily conserved module also known as Sushi domain, was first characterized in proteins with role in immunity, in particular in the complement system. In the past few years, proteins with CCP domains have been increasingly recognized for their role at neuronal synapses. Acetylcholine receptor clustering is regulated by CCP domain-containing proteins in <italic>Caenorhabditis elegans</italic> (<xref ref-type="bibr" rid="bib33">Gendrel et al., 2009</xref>) and in <italic>Drosophila melanogaster</italic> (<xref ref-type="bibr" rid="bib65">Nakayama et al., 2016</xref>). In humans, mutations in the CCP domain-containing secreted protein SRPX2 are associated with epilepsy and speech dysfunction, and SRPX2 knockdown leads to decreased synapse number and vocalization in mice (<xref ref-type="bibr" rid="bib77">Sia et al., 2013</xref>). Recently SRPX2 has been involved in the regulation of synapse elimination in the visual and somatosensory systems (<xref ref-type="bibr" rid="bib20">Cong et al., 2020</xref>). Despite the increase in the diversity of CCP domain-containing proteins in evolution (11 CCP domain-containing in <italic>C. elegans</italic> and 56 in humans; smart.embl.de), the function of many CCP domain-containing proteins remains unknown.</p><p>The mammalian <italic>SUSD4</italic> gene codes for a transmembrane protein with four extracellular CCP domains (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) and is highly expressed in the central nervous system (<xref ref-type="bibr" rid="bib39">Holmquist et al., 2013</xref>). The <italic>SUSD4</italic> gene is located in a genomic region deleted in patients with the 1q41q42 syndrome that includes developmental delays and intellectual deficiency (ID; <xref ref-type="bibr" rid="bib72">Rosenfeld et al., 2011</xref>). <italic>SUSD4</italic> is also among the 124 genes enriched in de novo missense mutations in a large cohort of individuals with autism spectrum disorders (ASDs) or IDs (<xref ref-type="bibr" rid="bib17">Coe et al., 2019</xref>). A copy number variation and several de novo mutations with a high CADD score, which indicates the deleteriousness of the mutations, have been described in the <italic>SUSD4</italic> gene in patients with ASDs (<xref ref-type="bibr" rid="bib25">Cuscó et al., 2009</xref>; denovo-db, Seattle, WA [<ext-link ext-link-type="uri" xlink:href="https://denovo-db.gs.washington.edu/denovo-db/">denovo-db.gs.washington.edu</ext-link>] 10, 2019). The SUSD4 protein has been described to regulate complement system activation in erythrocytes by binding the C1Q globular domain (<xref ref-type="bibr" rid="bib39">Holmquist et al., 2013</xref>). Interestingly, this domain is found in major synaptic regulators such as C1QA (<xref ref-type="bibr" rid="bib80">Stevens et al., 2007</xref>), CBLNs (<xref ref-type="bibr" rid="bib63">Matsuda et al., 2010</xref>; <xref ref-type="bibr" rid="bib90">Uemura et al., 2010</xref>), and C1Q-like proteins (<xref ref-type="bibr" rid="bib10">Bolliger et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Kakegawa et al., 2015</xref>; <xref ref-type="bibr" rid="bib78">Sigoillot et al., 2015</xref>). Altogether these studies point to a potential role of SUSD4 in synapse formation and/or function and in the etiology of neurodevelopmental disorders.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>SUSD4 is necessary for motor coordination adaptation and learning.</title><p>(<bold>A</bold>) Diagram of the protein SUSD4 showing its domain organization with four extracellular Complement Control Protein (CCP) domains, one transmembrane (TM) domain and a cytoplasmic domain (C<sub>T</sub>). (<bold>B</bold>) Quantitative RT-PCR shows an increase in <italic>Susd4</italic> mRNA expression (relative to the housekeeping gene <italic>Rpl13a</italic>) during postnatal development in the cerebellum and in the brainstem. Extracts were prepared from tissue samples of mice aged from 0 to 21 days (P0-21) and 3 months (3mo). Mean ± s.e.m. (n = 3 independent experiments). (<bold>C</bold>) HA-tagged SUSD4 is found in dendrites (left panel, single plane) and in some of the distal dendritic spines (right panel, arrowheads, projection of a 1.95 µm z-stack) in adult cerebellar Purkinje cells. Anti-HA and anti-GFP immunolabeling was performed on parasagittal cerebellar sections obtained from adult L7Cre mice after stereotaxic injection of AAV particles driving the expression of HA-SUSD4 and soluble GFP. Scale bars: 10 µm (left panel) and 2 µm (right panel). (<bold>D</bold>) Purkinje cells from primary mixed cerebellar cultures of L7Cre mice were transduced at 3 days in vitro (DIV3) with an HA-tagged SUSD4 expressing virus (AAV2-hSYN-DIO-HA-SUSD4-2A-eGFP) or with a control virus expressing GFP alone (AAV2-hSYN-DIO-eGFP), and immunostained in non-permeabilizing conditions at DIV17 for HA to localize surface SUSD4 (anti-HA, red), and in permeabilizing conditions to detect the green fluorescent protein (anti-GFP, green) and the endogenous GluD2 subunit (anti-GRID2, blue). Scale bar 5 µm. (<bold>E</bold>) Genomic structure of the <italic>Susd4</italic> gene. White boxes represent exons. Exon 1 is deleted in the <italic>Susd4</italic> loss-of-function mouse model. See also <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>. (<bold>F</bold>) Motor coordination and learning is deficient in adult male <italic>Susd4</italic> <sup>-/-</sup> (knockout [KO]) mice compared to age-matched <italic>Susd4</italic><sup>+/+</sup> (wild-type [WT]) littermates. Each mouse was tested three times per day during 5 consecutive days on an accelerating rotarod (4-40 r.p.m. in 10 min) and the time spent on the rotarod was measured. Mean ± s.e.m. (WT n = 11 and KO n = 7 mice, two-way ANOVA with repeated measures, interaction (time and genotype): **p=0.0079, F(14, 224)=2.22; time: ****p&lt;0.0001, F(14, 224)=3.469; genotype: p=0.0553, F(1, 16)=4.272). (<bold>G</bold>) In situ hybridization experiments were performed on brain sections from 1-month-old <italic>Susd4</italic> WT and <italic>Susd4</italic> KO mice to detect <italic>Susd4</italic> mRNA using a probe encompassing exons 2–5 (see also <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). <italic>Susd4</italic> expression was found in many regions of the brain in <italic>Susd4</italic> WT mice (see also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) including the cerebral cortex (CTX), the cerebellum (CB), and the brainstem (BS). No labeling was found in the brain of <italic>Susd4</italic>KO mice. Scale bar 500 µm.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical data to support graphs in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65712-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>Susd4</italic> mRNA expression in the developing mouse brain.</title><p>(<bold>A</bold>) <italic>Susd4</italic> mRNA expression was visualized in the brain of wild-type mice by in situ hybridization. Coronal (left) and sagittal (right) sections are presented at postnatal day 0 (P0), (<bold>B</bold>) postnatal day 7 (P7), and (<bold>C</bold>) postnatal day 30 (P30). <italic>Susd4</italic> expression was found in many regions including the cerebral cortex (CTX), the dentate gyrus (DG) and CA3 regions in the hippocampus (coronal section, left), the cerebellum (CB), in particular Purkinje cells (PCs), and the inferior olive (IO; sagittal section, right). Scale bars 250 and 500 μm (inset <bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Characterization of <italic>Susd4</italic> knockout (KO) mice.</title><p>(<bold>A</bold>) Structure of the <italic>Susd4</italic> gene and strategy for the generation of the KO mouse. The gene coding for the <italic>Susd4</italic> mRNA contains eight exons. The wild-type (WT) allele is presented indicating the localization of the primers used for genotyping and of the probes used for TaqMan RT-qPCR. In the KO allele, the 5'UTR and first exon are entirely deleted and replaced by the selection cassette. (<bold>B</bold>) <italic>Susd4</italic> expression was assessed by RT-PCR using primers encompassing exons 6-8 in extracts from cortex (CTX), cerebellum (CB), and brainstem (BS) in <italic>Susd4</italic> WT and <italic>Susd4</italic> KO mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Footprint analysis in <italic>Susd4</italic> knockout (KO) mice.</title><p>Footprint patterns of P30 <italic>Susd4</italic>WT and <italic>Susd4</italic> KO mice were quantitatively analyzed by measuring stride length for the fore paws (magenta) and hind paws (cyan), stance length for the forelimbs and hindlimbs, and print separation. Mean ± s.e.m. (WT n = 9 and KO n = 10 mice; unpaired Student’s t-test; forelimb stance: p=0.3059; forelimb stride: p=0.5882; hindlimb stance: p=0.4533; hindlimb stride: p=0.3580; print separation: *p=0.0148).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Normal cerebellar cytoarchitecture in <italic>Susd4</italic> knockout (KO) mice.</title><p>(<bold>A</bold>) Parasagittal sections of P30 <italic>Susd4</italic> wild-type (WT and <italic>Susd4</italic> KO cerebella were stained with Hoechst and used for quantitative analysis of the mean area of the cerebellum). Mean ± s.e.m. (n = 3 WT mice and n = 3 KO mice). Scale bar 500 µm. (<bold>B</bold>) Calbindin protein (CABP) immunostaining was used for quantitative analysis of the mean height of the molecular layer. Mean ± s.e.m. (WT n = 5 and KO n = 6 mice). Scale bar 30 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig1-figsupp4-v2.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>High-density microelectrode array (MEA) analysis of Purkinje cell spiking in acute cerebellar slices from <italic>Susd4</italic> knockout (KO) compared to <italic>Susd4</italic> wild type (WT).</title><p>(<bold>A</bold>) Image of a cerebellar acute slice from a WT mouse overlapped with the image of the color map of the MEA recording. Each pixel represents one channel, where the active units are in red. The black square highlights one of the channels. (<bold>B</bold>) Representative traces of electrical activity recorded in one channel from <italic>Susd4</italic> WT and KO mice. Each tick points out one action potential that has been detected and sorted by the Brainwave software. (<bold>C</bold>) Histograms of the mean firing rate, coefficient of variation (CV) of interspike intervals, and CV2. Mean ± s.e.m. (WT n = 5 and KO n = 4 mice; Mann-Whitney test; mean firing rate: p=0.2857; CV: p=0.4127; CV2: p=0.5373).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig1-figsupp5-v2.tif"/></fig></fig-group><p>Proper development and function of the cerebellar circuitry is central for motor coordination and adaptation, and a range of cognitive tasks (<xref ref-type="bibr" rid="bib4">Badura et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Hirai et al., 2005</xref>; <xref ref-type="bibr" rid="bib42">Ichise et al., 2000</xref>; <xref ref-type="bibr" rid="bib57">Lefort et al., 2019</xref>; <xref ref-type="bibr" rid="bib70">Rochefort et al., 2011</xref>; <xref ref-type="bibr" rid="bib89">Tsai et al., 2012</xref>). Cerebellar dysfunction is associated with several neurodevelopmental disorders including ASDs (<xref ref-type="bibr" rid="bib81">Stoodley, 2016</xref>; <xref ref-type="bibr" rid="bib82">Stoodley et al., 2018</xref>; <xref ref-type="bibr" rid="bib92">Wang et al., 2014</xref>). In this circuit, cerebellar Purkinje cells (PCs) receive more than a hundred thousand parallel fiber (PF) synapses whose formation, maintenance, and plasticity are essential for cerebellar-dependent learning (<xref ref-type="bibr" rid="bib35">Gutierrez-Castellanos et al., 2017</xref>; <xref ref-type="bibr" rid="bib37">Hirai et al., 2005</xref>; <xref ref-type="bibr" rid="bib44">Ito, 2006</xref>; <xref ref-type="bibr" rid="bib48">Kashiwabuchi et al., 1995</xref>). Postsynaptic LTD was first described at synapses between PFs and cerebellar PCs (<xref ref-type="bibr" rid="bib32">Gao et al., 2012</xref>; <xref ref-type="bibr" rid="bib38">Hirano, 2018</xref>; <xref ref-type="bibr" rid="bib43">Ito, 2001</xref>; <xref ref-type="bibr" rid="bib45">Ito and Kano, 1982</xref>), where it can be induced by conjunctive stimulation of PFs with the other excitatory input received by PCs, the climbing fiber (CF; <xref ref-type="bibr" rid="bib18">Coesmans et al., 2004</xref>; <xref ref-type="bibr" rid="bib43">Ito, 2001</xref>; <xref ref-type="bibr" rid="bib83">Suvrathan et al., 2016</xref>). The function of members of the C1Q family, such as CBLN1 and C1QL1, is essential for excitatory synapse formation and LTD in cerebellar PCs (<xref ref-type="bibr" rid="bib37">Hirai et al., 2005</xref>; <xref ref-type="bibr" rid="bib46">Kakegawa et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Matsuda et al., 2010</xref>; <xref ref-type="bibr" rid="bib78">Sigoillot et al., 2015</xref>; <xref ref-type="bibr" rid="bib90">Uemura et al., 2010</xref>), suggesting that proteins such as SUSD4, that interact with the C1Q globular domain, could regulate these processes.</p><p>Gene expression studies from our laboratory revealed that <italic>Susd4</italic> is highly expressed in the olivocerebellar system of the mouse. In order to uncover the potential link between SUSD4 and neurodevelopmental disorders, we sought to identify the role of SUSD4 in brain development and function, by analyzing the phenotype of a <italic>Susd4</italic> constitutive loss-of-function mouse model. Here, we show that knockout (KO) of the <italic>Susd4</italic> gene leads to deficits in motor coordination adaptation and learning, misregulation of synaptic plasticity in cerebellar PCs, as well as an impairment in the degradation of GluA2 AMPA receptor subunits after chemical induction of LTD. Proteomic analysis of SUSD4 binding complexes identified proteins that are involved in the regulation of several parameters controlling AMPA receptor turnover. We showed that SUSD4 directly interacts with E3 ubiquitin ligases of the NEDD4 family, which are known to regulate ubiquitination and degradation of their substrates. Our results also show that SUSD4 and GluA2 can interact in transfected HEK293 cells and partially colocalize in cultured PCs. Altogether, these findings suggest a function of SUSD4 in the regulation of GluA2 trafficking and degradation allowing proper synaptic plasticity and learning.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Susd4</italic> is broadly expressed in neurons during postnatal development</title><p>Given the potential synaptic role for SUSD4, its pattern of expression should correlate with the timing of synapse formation and/or maturation during postnatal development. In situ hybridization experiments using mouse brain sections showed high expression of <italic>Susd4</italic> mRNA in neurons in many regions of the central nervous system, including the cerebral cortex, the hippocampus, the cerebellum, and the brainstem (<xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). <italic>Susd4</italic> expression was already detected as early as postnatal day 0 (P0) in some regions but increased with brain maturation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). In the cerebellum, a structure where the developmental sequence leading to circuit formation and maturation is well described (<xref ref-type="bibr" rid="bib79">Sotelo, 2004</xref>), quantitative RT-PCR showed that <italic>Susd4</italic> mRNA levels start increasing at P7 and by P21 reach about 15 times the levels detected at birth (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). At P7, a major increase in synaptogenesis is observed in the cerebellum. At this stage, hundreds of thousands of PF excitatory synapses form on the distal dendritic spines of each PC, and a single CF arising from an inferior olivary neuron translocates and forms about 300 excitatory synapses on proximal PC dendrites (<xref ref-type="bibr" rid="bib58">Leto et al., 2016</xref>). In the brainstem, where cell bodies of inferior olivary neurons are located, the increase in <italic>Susd4</italic> mRNA expression occurs earlier, already by P3, and reaches a peak by P14 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Similarly to the cerebellum, this pattern of <italic>Susd4</italic> expression parallels the rate of synaptogenesis that increases during the first postnatal week in the inferior olive (<xref ref-type="bibr" rid="bib34">Gotow and Sotelo, 1987</xref>). To identify the subcellular localization of the SUSD4 protein and because of the lack of suitable antibodies for immunolabeling, viral particles enabling CRE-dependent coexpression of HA-tagged SUSD4 and GFP in neurons were injected in the cerebellum of adult mice expressing the CRE recombinase specifically in cerebellar PCs. Immunofluorescent labeling against the HA tag demonstrated the localization of HA-SUSD4 in dendrites and in some of the numerous dendritic spines present on the surface of distal dendrites (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). These spines are the postsynaptic compartments of PF synapses in PCs. Immunofluorescence analysis of transduced cultured PCs showed that HA-tagged SUSD4 could be immunolabeled in non-permeabilizing conditions and located at the surface of dendrites and spines (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Double labeling with the postsynaptic marker GluD2 (GRID2) further showed partial colocalization at the surface of some, but not all, spines. Therefore, the timing of <italic>Susd4</italic> mRNA expression during postnatal development and the subcellular localization of the SUSD4 protein in cerebellar PCs are in agreement with a potential role for SUSD4 in excitatory synapse formation and/or function.</p></sec><sec id="s2-2"><title><italic>Susd4</italic> loss-of-function leads to deficits in motor coordination and learning</title><p>To determine the synaptic function of SUSD4, we analyzed the phenotype of <italic>Susd4<sup>-/-</sup></italic> constitutive KO mice with a deletion of exon 1 (<xref ref-type="fig" rid="fig1">Figure 1E and G</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). RT-PCR using primers encompassing the last exons and the 3'UTR show the complete absence of <italic>Susd4</italic> mRNA in the brain of these <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). No obvious alterations of mouse development and behavior were detected in those mutants, an observation that was confirmed by assessment of their physical characteristics (weight, piloerection), basic behavioral abilities such as sensorimotor reflexes (whisker responses, eye blinking), and motor responses (open-field locomotion; see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We further assessed the behavior of <italic>Susd4</italic> KO mice for motor coordination and motor learning (<xref ref-type="bibr" rid="bib50">Kayakabe et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Lalonde and Strazielle, 2001</xref>; <xref ref-type="bibr" rid="bib71">Rondi-Reig et al., 1997</xref>). Using a footprint test, a slightly larger print separation of the front and hind paws in the <italic>Susd4</italic> KO mice was detected, but no differences in the stride length and stance width were found (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). In the accelerated rotarod assay, a classical test of motor adaptation and learning (<xref ref-type="bibr" rid="bib11">Buitrago et al., 2004</xref>), the mice were tested three times per day at 1 hr interval during 5 consecutive days. The <italic>Susd4</italic> KO mice performed as well as the <italic>Susd4<sup>+/+</sup></italic> (wild-type [WT]) littermate controls on the first trial (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, day 1, trial 1). This indicates that there is no deficit in their balance function, despite the slight change in fine motor coordination found in the footprint test. However, while the control mice improved their performance as early as the third trial on the first day, and further improved with several days of training, no learning could be observed for the <italic>Susd4</italic> KO mice either during the first day, or in the following days (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). These results show that <italic>Susd4</italic> loss-of-function leads to impaired motor coordination and learning in adult mice.</p></sec><sec id="s2-3"><title><italic>Susd4</italic> loss-of-function prevents LTD at cerebellar PF/PC synapses</title><p>Because of the high expression of <italic>Susd4</italic> in cerebellar PCs (<xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), we focused on this neuronal type to identify the morphological and functional consequences of <italic>Susd4</italic> loss-of-function. No deficits in the global cytoarchitecture of the cerebellum and morphology of PCs were found in <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). Using high-density microelectrode array (MEA), we assessed the spontaneous activity of PCs in acute cerebellar slices from <italic>Susd4</italic> KO mice and compared to <italic>Susd4</italic> WT mice (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>). No differences were detected in either the mean spiking frequency, the coefficient of variation (CV) of interspike intervals (ISIs), or the intrinsic variability of spike trains (CV2, <xref ref-type="bibr" rid="bib40">Holt and Douglas, 1996</xref>), indicating that the firing properties of PCs are not affected by <italic>Susd4</italic> loss-of-function.</p><p>Co-immunolabeling of PF presynaptic boutons using an anti-VGLUT1 antibody and of PCs using an anti-calbindin antibody in cerebellar sections from juvenile WT mice revealed an extremely dense staining in the molecular layer corresponding to the highly numerous PFs contacting PC distal dendritic spines (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The labeling pattern appeared to be similar in <italic>Susd4</italic> KO. High-resolution microscopy and quantitative analysis confirmed that there are no significant changes in the mean density and volume of VGLUT1 clusters following <italic>Susd4</italic> loss-of-function (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Electric stimulation of increasing intensity in the molecular layer allows the progressive recruitment of PFs (<xref ref-type="bibr" rid="bib52">Konnerth et al., 1990</xref>) and can be used to assess the number of synapses and basic PF/PC transmission using whole-cell patch-clamp recordings of PCs on acute cerebellar slices (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). No difference was observed in the amplitude and the kinetics of the responses to PF stimulation in PCs from <italic>Susd4</italic> KO and control littermate mice (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Furthermore, the probability of vesicular release in the presynaptic PF boutons, as assessed by measurements of paired-pulse facilitation (<xref ref-type="bibr" rid="bib2">Atluri and Regehr, 1996</xref>; <xref ref-type="bibr" rid="bib52">Konnerth et al., 1990</xref>; <xref ref-type="bibr" rid="bib91">Valera et al., 2012</xref>), was not changed at PF/PC synapses (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Finally, no differences in the frequency and amplitude of PF/PC-evoked quantal events were detected (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Thus, in accordance with the morphological analysis, <italic>Susd4</italic> invalidation has no major effect on the number and basal transmission of PF/PC synapses in the mouse.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Susd4</italic> loss-of-function leads to deficient long-term depression and facilitated long-term potentiation of parallel fiber (PF)/Purkinje cell synapses.</title><p>(<bold>A</bold>) Quantitative analysis of the morphology of PF presynaptic boutons immunolabeled by an anti-VGLUT1 antibody (red) in Purkinje cells (anti-CABP, blue). Quantifications of the density and the area of the VGLUT1 clusters did not reveal any difference between <italic>Susd4</italic> knockout (KO) and <italic>Susd4</italic> wild-type (WT) mice. Mean ± s.e.m. (WT n = 5 and KO n = 7 mice; VGLUT1 clusters density: Mann-Whitney test, p&gt;0.9999; area VGLUT1 clusters: unpaired Student’s t-test, p=0.3089). Scale bars 30 µm (left) and 10 µm (right). (<bold>B</bold>) Diagram of the setup for patch-clamp recordings (REC) of Purkinje cells in 300-µm-thick parasagittal cerebellar slices. PF and climbing fiber responses were elicited by electrical stimulation (STIM). ML: molecular layer; PCL: Purkinje cell layer; GCL: granule cell layer. (<bold>C</bold>) Input-output curve of the PF/Purkinje cell transmission. The amplitude of the elicited excitatory postsynaptic currents (EPSCs) increases with the intensity of the stimulus and is not significantly different between <italic>Susd4</italic> KO and WT littermates. The fitted curves for each genotype are presented in the inset. Representative sample traces are presented. Mean ± s.e.m. (WT n = 18 cells from eight mice and KO n = 16 cells from six mice; Kolmogorov-Smirnov test, p=0.8793). Short-term plasticity of PF/Purkinje cell synapses is not affected by <italic>Susd4</italic> loss-of-function. PFs were stimulated twice at 50 ms interval and the paired-pulse ratio (PPR) was calculated by dividing the amplitude of the second peak by the amplitude of the first peak. Mean ± s.e.m. (WT n = 21 cells from eight mice and KO n = 16 cells from six mice; Mann-Whitney test, p=0.9052). (<bold>D</bold>) Climbing fiber-dependent PF/Purkinje cell synapse long-term depression (LTD) is impaired in the absence of <italic>Susd4</italic> expression. LTD was induced by pairing stimulations of PFs and climbing fibers at 100 ms interval during 10 min at 0.5 Hz (see also <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The amplitude of the PF EPSC was measured using two consecutive PF stimulations at 50 ms interval. Representative sample traces are presented. Right: EPSC amplitudes from the last 10 min (purple) of recordings were used to calculate the LTD ratio relative to baseline. Mean ± s.e.m. (WT n = 16 cells from eleven mice and KO n = 14 cells from ten mice; two-tailed Wilcoxon signed rank test with null hypothesis of 100: WT **p=0.0063; KO p=0.2676; Mann-Whitney test, WT vs. KO *p=0.0476). (<bold>E</bold>) Loss-of-function of <italic>Susd4</italic> facilitates PF/Purkinje cell synapse long-term potentiation (LTP). Tetanic stimulation of only PFs at 0.3 Hz for 100 times (see also <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) induced LTP in <italic>Susd4</italic> KO Purkinje cells while inducing only a transient increase in PF transmission in WT Purkinje cells. Representative sample traces are presented. Right: EPSC amplitudes from the last 7 min (purple) were used to calculate the LTP ratio relative to baseline. Mean ± s.e.m. (WT n = 13 cells from nine mice and KO n = 8 cells from six mice; two-tailed Wilcoxon signed rank test with null hypothesis of 100: WT p=0.5879; KO *p=0.0234; Mann-Whitney test, WT vs. KO: *p=0.0199).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical data to support graphs in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65712-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Parallel fiber (PF)/Purkinje cell (PC) synapse excitatory postsynaptic currents (EPSCs) kinetics, long-term plasticity induction protocols, paired-pulse facilitation ratio, and delayed EPSC quanta.</title><p>(<bold>A</bold>) Schematic representation of the recording location (internal lobule VIa of the vermis). (<bold>B</bold>) No change in the rise time and decay of PF/PC EPSCs was induced by <italic>Susd4</italic> deletion. Mean ± s.e.m. (wild-type [WT] n = 21 cells from eight mice and knockout [KO] n = 16 cells from six mice; rise time: unpaired Student’s t-test, p=0.4570; decay time: Mann-Whitney test, p=0.7276). (<bold>C</bold>) PF long-term depression (LTD) induction protocol. (<bold>D</bold>) Paired-pulse ratio (A2/A1) during LTD measured at 20 Hz. Mean ± s.e.m. (WT n = 16 cells from 11 mice and KO n = 14 cells from 10 mice; two-way ANOVA with repeated measures, interaction (time and genotype): p=0.9935, F(39, 1092)=0.5222). (<bold>E</bold>) PF long-term potentiation (LTP) induction protocol. (<bold>F</bold>) Paired-pulse ratio (A2/A1) during LTP measured at 20 Hz. Mean ± s.e.m. (WT n = 13 cells from nine mice and KO n = 8 cells from six mice, two-way ANOVA with repeated measures, interaction (time and genotype): p=0.9366, F(39, 741)=0.6745). (<bold>G</bold>) Delayed PF-EPSC quanta were evoked by PF stimulation in the presence of strontium (Sr<sup>++</sup>) instead of calcium (Ca<sup>++</sup>) to induce desynchronization of fusion events. Representative sample traces are presented. The cumulative probability for the amplitude shows no difference with <italic>Susd4</italic> loss-of-function. The individual frequency values for each cell (measured as interevent interval) present no differences between the genotypes. No change in the time to peak and in the rise time of PF/PC synapse-delayed EPSC quanta was induced by <italic>Susd4</italic> deletion. Mean ± s.e.m. (WT n = 8 cells from six mice and KO n = 8 cells from five mice; amplitude: Kolmogorov-Smirnov distribution test, p=0.1667; frequency: Mann-Whitney test, p=0.1913; time to peak: Mann-Whitney test, p=0.6454; rise time 10-90%: unpaired Student’s t-test, p=0.6486).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Long-term synaptic plasticity of PF/PC synapses is involved in proper motor coordination and adaptation learning (<xref ref-type="bibr" rid="bib35">Gutierrez-Castellanos et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Hirano, 2018</xref>; <xref ref-type="bibr" rid="bib47">Kakegawa et al., 2018</xref>). We first assessed LTD in PF/PC synapses using conjunctive stimulation of PFs and CFs and whole-cell patch-clamp recordings of PCs in acute cerebellar slices from juvenile mice. The LTD induction protocol produced a 42% average decrease in the amplitude of PF excitatory postsynaptic currents (EPSCs) in PCs from WT mice while the paired-pulse facilitation ratio was not changed during the course of our recordings (<xref ref-type="fig" rid="fig2">Figure 2D</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). In <italic>Susd4</italic> KO PCs, the same LTD induction protocol did not induce any significant change in PF EPSCs during the 30 min recording period, showing that LTD induction and maintenance are greatly impaired in the absence of SUSD4 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). We then assessed LTP induction using high-frequency stimulation of PF in the absence of inhibition blockade as in <xref ref-type="bibr" rid="bib7">Binda et al., 2016</xref>. In slices from <italic>Susd4</italic> WT mice, tetanic stimulation every 3 s during 5 min induced only a transient increase in transmission of about 20% and the amplitude of the response returned to baseline after only 15 min (<xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). This result suggests that under our experimental conditions and in this particular genetic background, LTD might be favored in contrast to previously obtained results (<xref ref-type="bibr" rid="bib7">Binda et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Titley et al., 2019</xref>). In the case of <italic>Susd4</italic> KO PCs, the same protocol induced LTP with a 27% increase in transmission that was maintained after 35 min (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). These results indicate that the absence of <italic>Susd4</italic> expression promoted LTP induction at PF/PC synapses.</p><p>Lack of LTD of PF/PC synapses could arise from deficient CF/PC transmission. To test this possibility, we first crossed the <italic>Susd4</italic> KO mice with the <italic>Htr5b</italic>-GFP BAC transgenic line (<ext-link ext-link-type="uri" xlink:href="http://gensat.org/MMRRC_report.jsp?founder_id=17735">http://gensat.org/MMRRC_report.jsp?founder_id=17735</ext-link>) expressing soluble GFP specifically in inferior olivary neurons in the olivocerebellar system to visualize CFs. We found that CFs had a normal morphology and translocated along the proximal dendrites of their PC target in <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). We then assessed whether developmental elimination of supernumerary CFs was affected by <italic>Susd4</italic> invalidation using whole-cell patch-clamp recordings of PCs on cerebellar acute slices (<xref ref-type="bibr" rid="bib24">Crepel et al., 1976</xref>; <xref ref-type="bibr" rid="bib36">Hashimoto and Kano, 2003</xref>). No difference was found in the percentage of remaining multiply-innervated PCs in the absence of <italic>Susd4</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). We next used VGLUT2 immunostaining to label CF presynaptic boutons and analyze their morphology using high-resolution confocal microscopy and quantitative image analysis. VGLUT2 immunostaining revealed the typical CF innervation territory on PC proximal dendrites, extending up to about 80% of the molecular layer height both in control <italic>Susd4</italic> WT and in <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Furthermore, the number and density of VGLUT2 clusters were not significantly different between <italic>Susd4</italic> WT and <italic>Susd4</italic> KO mice. To test whether the lack of CF-dependent PF LTD was due to deficient CF transmission, we used whole-cell patch-clamp recordings of PCs in acute cerebellar slices. Contrary to what could have been expected, the typical all-or-none CF-evoked EPSC was detected in PCs from <italic>Susd4</italic> KO mice with increased amplitude when compared to WT PCs (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) while no differences in CF-EPSC kinetics were found (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Analysis of the complex spikes in current-clamp mode during LTD induction did not reveal any change in the complex spike waveform, with the same mean number of spikelets in response to the repeated CF stimulation in <italic>Susd4</italic> WT and <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Therefore, the lack of CF-dependent PF/PC synapse LTD in <italic>Susd4</italic> KO mice is not due to impaired CF/PC synapse formation or transmission. Measurements of evoked quantal events revealed an increase in the amplitude of the quantal EPSCs at CF/PC synapses from juvenile mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Paired-pulse facilitation and depression at PF/PC and CF/PC synapses, respectively, are similar between <italic>Susd4</italic> KO and control mice, both in basal conditions and during plasticity recordings (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), suggesting strongly that the changes in PF/PC synaptic plasticity and in CF/PC transmission in <italic>Susd4</italic> KO PCs have a postsynaptic origin. Overall our results show that <italic>Susd4</italic> loss-of-function in mice leads to a highly specific phenotype characterized by misregulation of postsynaptic plasticity in the absence of defects in synaptogenesis and in basal transmission in cerebellar PCs.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Transmission at the climbing fiber (CF)/Purkinje cell synapses is increased in <italic>Susd4</italic> knockout (KO) mice.</title><p>(<bold>A</bold>) Climbing fiber presynaptic boutons were immunostained with an anti-VGLUT2 antibody in cerebellar sections from P30 <italic>Susd4</italic> wild-type (WT) and <italic>Susd4</italic> KO mice. The extension of the CF synaptic territory was calculated by measuring the extent of the VGLUT2 (red) labeling relative to the height of the Purkinje cell dendritic tree (immunostained using an anti-CABP antibody, blue). Quantification of the mean density of VGLUT2 puncta and their mean area showed no differences between <italic>Susd4</italic> KO mice and their control littermates. Mean ± s.e.m. (WT n = 5 and KO n = 7 mice; VGLUT2 extension: Mann-Whitney test, p=0.6389; VGLUT2 area: unpaired Student’s t-test, p=0.4311; VGLUT2 density: unpaired Student’s t-test, p=0.8925). Scale bars 30 µm (left) and 10 µm (right). (<bold>B</bold>) Short-term synaptic plasticity of CF/Purkinje cell synapses was elicited by two consecutive stimulations at various intervals. The amplitude of the CF-elicited excitatory postsynaptic current (EPSC) was increased in <italic>Susd4</italic> KO mice compared to WT littermates. (WT n = 26 cells, nine mice and KO n = 26 cells, seven mice, Mann-Whitney test, **p=0.0066). No difference in the paired-pulse ratios (PPRs) was detected at any interval between <italic>Susd4</italic> KO mice and WT mice. Representative sample traces are presented. See also <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Mean ± s.e.m. (WT n = 12 cells from three mice and KO n = 17 cells from five mice; Kolmogorov-Smirnov test, p=0.4740). (<bold>C</bold>) Delayed CF-EPSC quanta were evoked by CF stimulation in the presence of Sr<sup>++</sup> instead of Ca<sup>++</sup> to induce desynchronization of fusion events. Representative sample traces are presented. The cumulative probability for the amplitude of the events together with the individual amplitude values for each event show an increased amplitude associated with <italic>Susd4</italic> loss-of-function. The individual frequency values for each cell (measured as interevent interval, IEI) present no differences between the genotypes. See also <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Mean ± s.e.m. (WT n = 10 cells from six mice and KO n = 8 cells from three mice; amplitude: Kolmogorov-Smirnov distribution test, ***p&lt;0.0001; frequency: Mann-Whitney test, p=0.6334).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical data to support graphs in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65712-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Characteristics of the climbing fiber (CF)/Purkinje cell (PC) synapse.</title><p>(<bold>A</bold>) CFs were visualized in <italic>Susd4</italic> wild-type (WT) and knockout (KO) mice crossed with Htr5b-eGFP reporter mice expressing the green fluorescent protein (GFP) specifically in inferior olivary neurons. Anti-GFP and anti-CABP (to visualize PCs) immunolabeling was performed on parasagittal sections of P30 mice and showed no qualitative differences in the absence of <italic>Susd4</italic> expression. Scale bar 10 µm. (<bold>B</bold>) Patch-clamp recordings of PCs showed a similar percentage of mono- (one climbing fiber) and multi-innervation (&gt;1 CFs) of PCs in P30 <italic>Susd4</italic> KO and WT mice, as measured by the number of steps elicited by electrical stimulation of the CFs (WT n = 26 cells from nine mice and KO n = 26 cells from seven mice; chi-square test, p=0.5520). (<bold>C</bold>) No change in the rise and decay times of CF/PC excitatory postsynaptic currents (EPSCs) was induced by <italic>Susd4</italic> deletion. Mean ± s.e.m. (WT n = 26 cells from nine mice and KO n = 26 cells from seven mice; rise time: unpaired Student’s t-test, p=0.3750; decay time: Mann-Whitney test, p=0.7133). (<bold>D</bold>) No change in the time to peak and in the rise time of CF/PC synapse-delayed EPSC quanta was induced by <italic>Susd4</italic> loss-of-function. Mean ± s.e.m. (WT n = 10 cells from six mice and KO n = 8 cells from three mice; time to peak: unpaired Student’s t-test, p=0.1692; rise time 10-90%: Mann-Whitney test, p=0.0639). (<bold>E</bold>) CF/PC transmission was monitored during long-term depression (LTD) induction in current-clamp mode. Representative traces of the CF-EPSP are shown. The quantification of the number of spikelets (spikes induced by repeated CF stimulation [<xref ref-type="bibr" rid="bib62">Mathy et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Titley et al., 2019</xref>]) did not reveal any difference between WT and KO PCs (unpaired Student’s t-test, p=0.5791). Bottom: Measurements of the CF-EPSP area and hyperpolarization area during the LTD induction protocol. Mean ± s.e.m. (WT n = 16 cells from 11 mice and KO n = 14 cells from 10 mice).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title><italic>Susd4</italic> loss-of-function leads to deficient activity-dependent degradation of GluA2</title><p>What are the mechanisms that allow regulation of long-term synaptic plasticity by SUSD4? The lack of LTD at PF/PC synapses and our analysis of evoked quantal events suggested the involvement of SUSD4 in the regulation of postsynaptic receptor numbers. GluA2 subunits are present in most AMPA receptor channels in PC excitatory synapses (<xref ref-type="bibr" rid="bib61">Masugi-Tokita et al., 2007</xref>; <xref ref-type="bibr" rid="bib97">Zhao et al., 1998</xref>). To assess whether <italic>Susd4</italic> loss-of-function leads to misregulation of the GluA2 subunits at PC excitatory synapses, we first performed co-immunolabeling experiments using an anti-GluA2 antibody and an anti-VGLUT2 antibody on cerebellar sections followed by high-resolution microscopy. Several GluA2 clusters of varying sizes were detected in close association with each VGLUT2 presynaptic cluster corresponding to a single CF release site, while very small and dense GluA2 clusters were found in the rest of the molecular layer which mostly correspond to GluA2 clusters at the PF/PC synapses (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). No obvious change in GluA2 distribution in the molecular layer in <italic>Susd4</italic> KO mice was found when compared to controls, in accordance with normal basal transmission in PF/PC synapses (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Quantitative analysis of the GluA2 clusters associated with VGLUT2-labeled CF presynaptic boutons did not reveal a significant change in the total mean intensity of GluA2 clusters per CF presynaptic bouton (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). However, the proportion of CF presynaptic boutons with no GluA2 cluster was smaller in juvenile <italic>Susd4</italic> KO mice than in WT mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). This decrease partially explains the increase in the amplitude of quantal EPSCs and CF transmission (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of SUSD4 leads to misregulation of the AMPA receptor subunit GluA2.</title><p>(<bold>A</bold>) The number of GluA2 clusters (anti-GluA2 immunolabeling, green) per climbing fiber presynaptic bouton (anti-VGLUT2 immunolabeling, red) and their intensity were quantified in cerebellar sections of juvenile <italic>Susd4</italic> knockout (KO) mice and <italic>Susd4</italic> wild-type (WT) littermates. Cumulative plot for the mean GluA2 intensity per VGLUT2 bouton shows no significant change between WT and KO. The distribution of the VGLUT2 boutons according to the number of associated GluA2 clusters is significantly different between WT and KO. Mean ± s.e.m. (WT n = 5 and KO n = 5 mice; intensity: Kolmogorov-Smirnov test, p=0.5009; distribution: chi-square contingency test, ****p&lt;0.0001). Scale bars 30 µm (top) and 15 µm (bottom). (<bold>B</bold>) Activity-dependent changes in surface localization of GluA2 was studied in cerebellar acute slices from <italic>Susd4</italic> KO mice and control <italic>Susd4</italic> WT littermates using a chemical LTD protocol (cLTD; K-Glu: K<sup>+</sup>50 mM and glutamate 10 μM for 5 min followed by 30 min of recovery). Surface biotinylation of GluA2 subunits was followed by affinity purification of biotinylated GluA2 subunits and anti-GluA2 immunoblot analysis. The fraction of biotinylated GluA2 was obtained by measuring the levels of biotinylated GluA2 in affinity-purified samples and total GluA2 normalized to βACTIN in input samples for each condition. The ratios between the fraction of biotinylated GluA2 after cLTD and control conditions are represented. Mean ± s.e.m. (n = 8 independent experiments; two-tailed Student’s one sample t-test was performed on the ratios with a null hypothesis of 1, P<sub>WT</sub> = 0.0212 and P<sub>KO</sub> = 0.0538). (<bold>C</bold>) Activity-dependent degradation of GluA2 was assessed in cerebellar acute slices from <italic>Susd4</italic> KO and WT mice after induction of chemical LTD (cLTD; K-Glu: K<sup>+</sup>50 mM and glutamate 10 μM for 5 min followed by 30 min of recovery). This degradation was absent when slices were incubated with 100 µg/mL leupeptin and with 50 µM MG132 (to inhibit lysosomal and proteasome degradation, respectively), or when slices were obtained from <italic>Susd4</italic> KO mice. Band intensities of GluA2 were normalized to βACTIN. The ratios between levels with cLTD induction (K-Glu) and without cLTD induction (CTL) are represented. See also <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>. Mean ± s.e.m. (n = 8 independent experiments; two-tailed Student’s one sample t-test was performed on the ratios with a null hypothesis of 1, P<sub>WT</sub> = 0.0107, P<sub>WT+Leu/MG132</sub> = 0.3755, P<sub>KO</sub> = 0.3176 and P<sub>KO+Leu/MG132</sub> = 0.2338). (<bold>D</bold>) Purkinje cells from primary cerebellar cultures of L7Cre mice were transduced at 3 days in vitro (DIV3) with AAV particles driving the expression of HA-SUSD4 and soluble GFP (AAV2-hSYN-DIO-HA-SUSD4-2A-eGFP) and immunolabeled at DIV17 in non-permeabilizing conditions to localize surface SUSD4 (anti-HA, red) and surface GluA2 subunits (anti-GluA2, blue). Direct green fluorescent protein is shown (GFP, green). Right panels are binarized images of the anti-HA and anti-GluA2 immunolabelings and of the colocalization of these signals (maximum projection of a 1.8 µm z-stack). Scale bar 5 µm.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical data to support graphs in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65712-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Basal surface GluA2 levels and total GluA2 and GluD2 levels in SUSD4 knockout (KO) mice.</title><p>(<bold>A</bold>) Surface GluA2 levels (relative to normalized GluA2 input) in basal conditions were not different on average in acute cerebellar slices from <italic>Susd4</italic> KO when compared to slices from wild-type (WT) mice. (<bold>B</bold>) and (<bold>C</bold>) Total protein levels (normalized to βACTIN) of GluA2 (<bold>B</bold>) and GluD2 (<bold>C</bold>) were not changed in acute cerebellar slices from <italic>Susd4</italic> WT or KO mice in basal conditions. Mean ± s.e.m. (n = 8 independent experiments; unpaired Student’s t-test; GluA2: p=0.5424; GluD2: p=0.6821). (<bold>D</bold>) Cerebellar acute slices from control WT and <italic>Susd4</italic> KO mice were incubated to induce chemical LTD (cLTD; K-Glu: K<sup>+</sup>50 mM and glutamate 10 μM for 5 min followed by 30 min of recovery). Slices were incubated with 100 µg/mL leupeptin and with 50 µM MG132 (to inhibit lysosomal and proteasome degradation, respectively). Band intensities of GluD2 were normalized to βACTIN. The ratios between levels with cLTD induction (K-Glu) and without cLTD induction (CTL) are represented. Mean ± s.e.m. (n = 8 independent experiments; two-tailed Student’s one sample t-test was performed on the ratios with a null hypothesis of 1, P<sub>WT</sub> = 0.4973, P<sub>WT+Leu/MG132</sub> = 0.1433, P<sub>KO</sub> = 0.3143, P<sub>KO+Leu/MG132</sub> = 0.9538, n.s. = not significant).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Interaction and colocalization of HA-SUSD4 and the AMPA receptor subunit GluA2.</title><p>(<bold>A</bold>) SUSD4 interaction with GluA2 was assessed by co-immunoprecipitation using HEK293 cells transfected with SEP-GluA2 together with PVRL3α as a control or HA-SUSD4. Affinity purification was performed with an anti-GFP antibody and extracts were probed for co-immunoprecipitation of GluA2 (with an anti-GluA2 antibody) and of HA-SUSD4 (anti-HA antibody) or PVRL3α (anti-PVRL3α antibody). βACTIN was used as a loading control. Representative of N = 3 independent experiments. (<bold>B</bold>) Mouse hippocampal neurons were transfected at 13 days in vitro (DIV13) with a GFP-tagged SUSD4 construct and immunostained at DIV17 for green fluorescent protein (GFP, green) to localize SUSD4 and for the endogenous GluA2 subunit (anti-GluA2, red). The arrowheads indicate the spines containing SUSD4 and GluA2. Scale bar 10 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig4-figsupp2-v2.tif"/></fig></fig-group><p>In cerebellar PCs, regulation of the GluA2 subunits at synapses and of their trafficking is essential for PF LTD (<xref ref-type="bibr" rid="bib16">Chung et al., 2003</xref>; <xref ref-type="bibr" rid="bib96">Xia et al., 2000</xref>). To test whether activity-dependent surface localization of GluA2-containing AMPA receptors is affected by loss of <italic>Susd4</italic>, we set up a biochemical assay in which we induced chemical LTD (cLTD) in acute cerebellar slices (<xref ref-type="bibr" rid="bib51">Kim et al., 2017</xref>) and performed surface biotinylation of GluA2 subunits followed by immunoblot quantification. In control conditions, the mean baseline levels of surface GluA2 were not significantly different between <italic>Susd4</italic> WT and <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). As expected, after cLTD a 35% mean reduction of surface GluA2 receptors was measured in slices from WT mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>; p=0.0212, two-tailed Student’s t test with a null hypothesis of 1). In acute slices from <italic>Susd4</italic> KO mice, a similar, but not statistically significant, mean reduction of surface GluA2 receptors was detected after cLTD (28%; p=0.0538, two-tailed Student’s t test with a null hypothesis of 1). Thus, SUSD4 loss-of-function does not lead on average to a major change in the activity-dependent regulation of the number of surface GluA2 subunits.</p><p>Another parameter that needs to be controlled for proper LTD in PCs is the total number of AMPA receptors in the recycling pool and the targeting of AMPA receptors to late endosomes and lysosomes (<xref ref-type="bibr" rid="bib51">Kim et al., 2017</xref>). Lack of LTD and facilitation of LTP in <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>) suggest that GluA2 activity-dependent targeting to the endolysosomal compartment and its degradation is affected by <italic>Susd4</italic> loss-of-function. Using our cLTD assay in cerebellar slices, we measured the total GluA2 levels either in control conditions or in the presence of inhibitors of the proteasome (MG132) and of lysosomal degradation (leupeptin). The comparison of the GluA2 levels in the presence of both inhibitors and in control conditions allowed us to estimate the GluA2 degraded pool, regardless of the mechanism behind this degradation. On average, total GluA2 levels were not significantly different between <italic>Susd4</italic> WT and <italic>Susd4</italic> KO cerebellar slices in basal conditions (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), in accordance with our morphological and electrophysiological analysis of PF/PC synapses (<xref ref-type="fig" rid="fig2">Figure 2A and C</xref>). In slices from WT mice, chemical induction of LTD induced a significant reduction of 13% in total GluA2 protein levels (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). This reduction was prevented by incubation with the mixture of degradation inhibitors, MG132 and leupeptin, showing that it corresponds to the pool of GluA2 degraded in an activity-dependent manner (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In slices from <italic>Susd4</italic> KO mice, this activity-dependent degradation of GluA2 was completely absent. Additionally, the chemical induction of LTD had no effect on the total protein levels of GluD2, another synaptic receptor highly present at PF/PC postsynaptic densities, either in slices from WT or from <italic>Susd4</italic> KO mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Thus, SUSD4 specifically controls the activity-dependent degradation of GluA2-containing AMPA receptors during LTD.</p><p>Finally, co-immunoprecipitation experiments were performed using extracts from heterologous HEK293 cells transfected with SEP-tagged GluA2 and HA-tagged SUSD4 or the transmembrane protein PVRL3α as a control. After affinity purification of SEP-GluA2, HA-SUSD4 was detected in affinity-purified extracts while PVRL3α was not, showing the specific interaction of SEP-GluA2 and HA-SUSD4 in transfected HEK293 cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). In order to assess the potential colocalization of SUSD4 and GluA2 in neurons, we used a Cre-dependent AAV construct to express HA-tagged SUSD4 in cultured PCs (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) and performed immunolabeling of surface GluA2 subunits. Clusters of HA-tagged SUSD4 partially colocalize with GluA2 clusters at the surface of some dendritic spines (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Partial colocalization of GluA2 and SUSD4 in neurons was also confirmed in transfection experiments in hippocampal neurons (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Thus, SUSD4 could regulate activity-dependent degradation of GluA2-containing AMPA receptors through a direct interaction.</p></sec><sec id="s2-5"><title>SUSD4 interacts with NEDD4 ubiquitin ligases</title><p>To better understand how SUSD4 regulates the number of GluA2-containing AMPA receptors at synapses, we searched for SUSD4 molecular partners by affinity purification of cerebellar synaptosome extracts using GFP-tagged SUSD4 as a bait (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Interacting partners were identified by proteomic analysis using liquid chromatography with tandem mass spectrometry (LC-MS/MS; <xref ref-type="bibr" rid="bib75">Savas et al., 2014</xref>). Twenty-eight candidates were identified including proteins with known function in the regulation of AMPA receptor turnover (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Several candidates were functionally linked to ubiquitin ligase activity by gene ontology (GO) term analysis (<xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="table" rid="table1">Table 1</xref>). In particular, five members of the NEDD4 subfamily of HECT E3 ubiquitin ligases were found as potential interacting partners, three of them (<italic>Nedd4l</italic>, <italic>Wwp1</italic>, and <italic>Itch</italic>) exhibiting the highest enrichment factors among the 28 candidates. Ubiquitination is a post-translational modification essential for the regulation of protein turnover and trafficking in cells (<xref ref-type="bibr" rid="bib85">Tai and Schuman, 2008</xref>). A survey of the expression of HECT-ubiquitin ligases shows that different members of the NEDD4 subfamily are broadly expressed in the mouse brain, however with only partially overlapping patterns (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, <ext-link ext-link-type="uri" xlink:href="http://mouse.brain-map.org">http://mouse.brain-map.org</ext-link>, Allen Brain Atlas). <italic>Nedd4</italic> and <italic>Wwp1</italic> are the most broadly expressed, including in neurons that also express <italic>Susd4</italic>, such as hippocampal neurons, inferior olivary neurons in the brainstem, and cerebellar PCs. Immunoblot analysis of affinity-purified synaptosome extracts confirmed the interaction of SUSD4 with NEDD4, ITCH, and WWP1 (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Removal of the intracellular domain of SUSD4 (SUSD4ΔC<sub>T</sub> mutant) prevented this interaction demonstrating the specificity of SUSD4 binding to NEDD4 ubiquitin ligases (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>SUSD4 binds NEDD4 ubiquitin ligases, known regulators of AMPA receptor turnover and degradation.</title><p>(<bold>A</bold>) Mass spectrometry identification of SUSD4 interactors. Left: Affinity purification from cerebellar synaptosomes was performed using either GFP-SUSD4 as a bait or GFP as a control. Proteins were then resolved using SDS-PAGE followed by immunoblot for anti-GFP and coomassie staining of proteins. Right: Gene ontology (GO) enrichment analysis network (Molecular Function category) of the 28 candidate proteins (Cytoscape plugin ClueGO) identified in affinity purified samples (A) by liquid chromatography with tandem mass spectrometry (LC MS/MS). The ubiquitin ligase activity term is significantly enriched in particular due to the identification of several members of the NEDD4 family of HECT ubiquitin ligases. See also <xref ref-type="table" rid="table1">Table 1</xref> (n = 3 independent experiments). (<bold>B</bold>) Immunoblot confirmation of SUSD4 interaction with NEDD4 ubiquitin ligases. Affinity purification from cerebellar synaptosomes was performed using full-length SUSD4 (HA-tagged, HA-SUSD4), a mutant lacking the C-terminal tail (HA-SUSD4ΔC<sub>T</sub>), or GFP as a bait. Proteins were then resolved using SDS-PAGE followed by immunoblot for NEDD4, ITCH, WWP1, or HA-SUSD4 (anti-HA). HA-SUSD4 interacts with all three members of the NEDD4 family. This interaction is lost when the C-terminal tail of SUSD4 is deleted or when GFP is used instead of SUSD4 as a control. (<bold>C</bold>) Schematic representation of HA-tagged SUSD4 and different mutant constructs: SUSD4ΔC<sub>T</sub> (lacking the cytoplasmic tail), SUSD4ΔN<sub>T</sub> (lacking the extracellular domain), SUSD4N<sub>T</sub> (lacking the transmembrane and intracellular domains), SUSD4ΔPY (point mutation of the PPxY site), SUSD4ΔLY (point mutation of the LPxY), and SUSD4ΔPY/LY (double mutant at both PPxY and LPxY). (<bold>D</bold>) SUSD4 interaction with GluA2 and NEDD4 was assessed by co-immunoprecipitation using HEK293 cells transfected with SEP-GluA2 together with PVRL3α as a control or one of the HA-SUSD4 constructs represented in (<bold>C</bold>). Affinity purification was performed with an anti-HA antibody and extracts were probed for co-immunoprecipitation of GluA2 (with an anti-GluA2 antibody) and of the HECT ubiquitin ligase NEDD4 (anti-NEDD4 antibody). Co-immunoprecipitated GluA2 levels are normalized to input GluA2 and then represented as relative to the immunoprecipitated levels for each SUSD4 construct. N = 3 independent experiments. (<bold>E</bold>) Potential interactors of SUSD4 control several parameters of AMPA receptor turnover. Three different pools of AMPA receptors are found in dendrites and spines: synaptic, extrasynaptic, and intracellular. AMPA receptors are synthetized and delivered close to the synaptic spine to reach the synaptic surface. At the surface, AMPA receptors can move laterally (lateral diffusion) or vertically by endocytosis and exocytosis. Endocytosis can be mediated by clathrin (CM-endocytosis) or be clathrin-independent (CI-endocytosis). CM-endocytosis is often related to activity-dependent processes. After endocytosis, AMPA receptors can choose between two different pathways from the early endosomes, one for recycling and the other for degradation. Potential molecular partners of SUSD4 identified by our proteomic analysis could regulate AMPA receptor turnover at several levels of this cycle (in red).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical data to support graphs in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65712-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Expression of HECT ubiquitin ligases in adult mouse brain.</title><p>(<bold>A</bold>) Schematic representation of four SUSD4 interactors: NEDD4, NEDD4L, ITCH, and WWP1. Legends: N<sub>T</sub>, N-terminus; HECT, homologous to the E6-AP C-terminus domain; C<sub>T</sub>, C-terminus. (<bold>B</bold>) Pattern of expression of <italic>Nedd4</italic> (RP_050712_03_C08), (<bold>C</bold>) <italic>Nedd4l</italic> (RP_040625_01_G10), (<bold>D</bold>) <italic>Itch</italic> (RP_050222_01_H06), and (<bold>E</bold>) <italic>Wwp1</italic> (RP_050510_02_E12) mRNA in the adult mouse brain. From Allen Brain Atlas (<ext-link ext-link-type="uri" xlink:href="http://www.brain-map.org">http://www.brain-map.org</ext-link>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Total protein levels in HEK293 cells transfected with SEP-GluA2 and different SUSD4 mutant constructs (related to <xref ref-type="fig" rid="fig5">Figure 5C and D</xref>).</title><p>HEK293 cells were transfected with SEP-GluA2 together with PVRL3α as a control or one of the HA-SUSD4 constructs for co-immunoprecipitation experiments. Input extracts were probed for GluA2 (with an anti-GluA2 antibody), the HECT ubiquitin ligase NEDD4 (anti-NEDD4 antibody), and the HA-tagged SUSD4 constructs (anti-HA antibody). βACTIN was used as a loading control. Representative image of N = 3 independent experiments. Quantifications represent the GluA2 or HA band intensity normalized to the intensity of the βACTIN band.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65712-fig5-figsupp2-v2.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>List of SUSD4 interactors.</title><p>Proteomic identification of SUSD4 interacting partners affinity-purified from synaptosomes extracts using GFP-SUSD4 as a bait (≥2 unique peptides; enrichment factor ≥4).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">UniProtKB accession num.</th><th valign="top">Protein name</th><th valign="top">Gene name</th><th valign="top">Mol. weight (kDa)</th><th valign="top">Unique peptides</th><th valign="top">MS/MS count</th><th valign="top">Enrichment factor</th></tr></thead><tbody><tr><td valign="top">Q8CFI0</td><td valign="top">E3 ubiquitin-protein ligase NEDD4-like</td><td valign="top"><italic>Nedd4l</italic></td><td valign="top">115,42</td><td valign="top">28</td><td valign="top">319</td><td valign="top">159.5</td></tr><tr><td valign="top">Q8BH32</td><td valign="top">Sushi domain-containing protein 4</td><td valign="top"><italic>Susd4</italic></td><td valign="top">53,796</td><td valign="top">4</td><td valign="top">97</td><td valign="top">48.5</td></tr><tr><td valign="top">Q8BZZ3</td><td valign="top">NEDD4-like E3 ubiquitin-protein ligase WWP1</td><td valign="top"><italic>Wwp1</italic></td><td valign="top">104,69</td><td valign="top">13</td><td valign="top">90</td><td valign="top">45</td></tr><tr><td valign="top">Q8C863</td><td valign="top">E3 ubiquitin-protein ligase Itchy</td><td valign="top"><italic>Itch</italic></td><td valign="top">98,992</td><td valign="top">24</td><td valign="top">83</td><td valign="top">41.5</td></tr><tr><td valign="top">Q3TXU5</td><td valign="top">Deoxyhypusine synthase</td><td valign="top"><italic>Dhps</italic></td><td valign="top">40,642</td><td valign="top">9</td><td valign="top">81</td><td valign="top">40.5</td></tr><tr><td valign="top">Q9DBG3</td><td valign="top">AP-2 complex subunit beta</td><td valign="top"><italic>Ap2b1</italic></td><td valign="top">104,58</td><td valign="top">9</td><td valign="top">47</td><td valign="top">23.5</td></tr><tr><td valign="top">P50171</td><td valign="top">Estradiol 17-beta-dehydrogenase 8</td><td valign="top"><italic>Hsd17b8</italic></td><td valign="top">26,588</td><td valign="top">2</td><td valign="top">32</td><td valign="top">16</td></tr><tr><td valign="top">Q9DBH0</td><td valign="top">NEDD4-like E3 ubiquitin-protein ligase WWP2</td><td valign="top"><italic>Wwp2</italic></td><td valign="top">98,76</td><td valign="top">14</td><td valign="top">31</td><td valign="top">15.5</td></tr><tr><td valign="top">Q922R8</td><td valign="top">Protein disulfide-isomerase A6</td><td valign="top"><italic>Pdia6</italic></td><td valign="top">48,1</td><td valign="top">8</td><td valign="top">26</td><td valign="top">13</td></tr><tr><td valign="top">P27773</td><td valign="top">Protein disulfide-isomerase A3</td><td valign="top"><italic>Pdia3</italic></td><td valign="top">56,678</td><td valign="top">12</td><td valign="top">24</td><td valign="top">12</td></tr><tr><td valign="top">P17427</td><td valign="top">AP-2 complex subunit alpha-2</td><td valign="top"><italic>Ap2a2</italic></td><td valign="top">104,02</td><td valign="top">7</td><td valign="top">23</td><td valign="top">11.5</td></tr><tr><td valign="top">Q8BWG8</td><td valign="top">Beta-arrestin-1</td><td valign="top"><italic>Arrb1</italic></td><td valign="top">46,972</td><td valign="top">4</td><td valign="top">23</td><td valign="top">11.5</td></tr><tr><td valign="top">Q91WC3</td><td valign="top">Long-chain fatty acid – CoA ligase 6</td><td valign="top"><italic>Acsl6</italic></td><td valign="top">78,016</td><td valign="top">11</td><td valign="top">22</td><td valign="top">11</td></tr><tr><td valign="top">P27546</td><td valign="top">Microtubule-associated protein 4</td><td valign="top"><italic>Map4</italic></td><td valign="top">117,43</td><td valign="top">9</td><td valign="top">18</td><td valign="top">9</td></tr><tr><td valign="top">Q505F5</td><td valign="top">Leucine-rich repeat-containing protein 47</td><td valign="top"><italic>Lrrc47</italic></td><td valign="top">63,589</td><td valign="top">9</td><td valign="top">17</td><td valign="top">8.5</td></tr><tr><td valign="top">Q9Z2H5</td><td valign="top">Band 4.1-like protein 1</td><td valign="top"><italic>Epb41l1</italic></td><td valign="top">98,314</td><td valign="top">8</td><td valign="top">17</td><td valign="top">8.5</td></tr><tr><td valign="top">P46935</td><td valign="top">E3 ubiquitin-protein ligase NEDD4</td><td valign="top"><italic>Nedd4</italic></td><td valign="top">102,71</td><td valign="top">7</td><td valign="top">17</td><td valign="top">8.5</td></tr><tr><td valign="top">Q8BMK4</td><td valign="top">Cytoskeleton-associated protein 4</td><td valign="top"><italic>Ckap4</italic></td><td valign="top">63,691</td><td valign="top">11</td><td valign="top">16</td><td valign="top">8</td></tr><tr><td valign="top">P47708</td><td valign="top">Rabphilin-3A</td><td valign="top"><italic>Rph3a</italic></td><td valign="top">75,488</td><td valign="top">7</td><td valign="top">15</td><td valign="top">7.5</td></tr><tr><td valign="top">P42128</td><td valign="top">Forkhead box protein K1</td><td valign="top"><italic>Foxk1</italic></td><td valign="top">74,919</td><td valign="top">6</td><td valign="top">15</td><td valign="top">7.5</td></tr><tr><td valign="top">P62812</td><td valign="top">Gamma-aminobutyric acid receptor subunit alpha-1</td><td valign="top"><italic>Gabra1</italic></td><td valign="top">51,753</td><td valign="top">7</td><td valign="top">14</td><td valign="top">7</td></tr><tr><td valign="top">Q60737</td><td valign="top">Casein kinase II subunit alpha</td><td valign="top"><italic>Csnk2a1</italic></td><td valign="top">45,133</td><td valign="top">7</td><td valign="top">13</td><td valign="top">6.5</td></tr><tr><td valign="top">Q99KV1</td><td valign="top">DnaJ homolog subfamily B member 11</td><td valign="top"><italic>Dnajb11</italic></td><td valign="top">40,555</td><td valign="top">5</td><td valign="top">10</td><td valign="top">5</td></tr><tr><td valign="top">P63037</td><td valign="top">DnaJ homolog subfamily A member 1</td><td valign="top"><italic>Dnaja1</italic></td><td valign="top">44,868</td><td valign="top">4</td><td valign="top">10</td><td valign="top">5</td></tr><tr><td valign="top">Q9QY76</td><td valign="top">Septin-11</td><td valign="top"><italic>Sept11</italic></td><td valign="top">49,694</td><td valign="top">5</td><td valign="top">9</td><td valign="top">4.5</td></tr><tr><td valign="top">O70318</td><td valign="top">Band 4.1-like protein 2</td><td valign="top"><italic>Epb41l2</italic></td><td valign="top">109,94</td><td valign="top">6</td><td valign="top">8</td><td valign="top">4</td></tr><tr><td valign="top">P62196</td><td valign="top">26S protease regulatory subunit 8</td><td valign="top"><italic>Psmc5</italic></td><td valign="top">45,626</td><td valign="top">5</td><td valign="top">8</td><td valign="top">4</td></tr><tr><td valign="top">Q9Z2Q6</td><td valign="top">Septin-5</td><td valign="top"><italic>Sept5</italic></td><td valign="top">42,747</td><td valign="top">4</td><td valign="top">8</td><td valign="top">4</td></tr></tbody></table></table-wrap><p>The NEDD4 subfamily of HECT ubiquitin ligases is known to ubiquitinate and target for degradation many key signaling molecules, including GluA1- and GluA2-containing AMPA receptors (<xref ref-type="bibr" rid="bib76">Schwarz et al., 2010</xref>; <xref ref-type="bibr" rid="bib95">Widagdo et al., 2017</xref>). Ubiquitin ligases of the NEDD4 family bind variants of PY motifs on target substrates and adaptors (<xref ref-type="bibr" rid="bib12">Chen et al., 2017</xref>). However, GluA1 and GluA2 subunits lack any obvious motif of this type. In contrast, two potential PY binding sites are present in the intracellular domain of SUSD4 (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). To test whether SUSD4 and GluA2 interaction is affected by SUSD4 binding to NEDD4 ubiquitin ligases, co-immunoprecipitation experiments were performed on extracts from heterologous HEK293 cells transfected with SEP-tagged GluA2 and various HA-tagged SUSD4 constructs (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). In addition to several deletion constructs of SUSD4, we generated single- and double-point mutants of the two PY motifs in its intracellular tail (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Lack of the cytoplasmic domain completely abrogated binding of NEDD4 to SUSD4, confirming the results obtained using synaptosome extracts (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Deletion of the N-terminus domain of SUSD4 did not affect NEDD4 binding. Furthermore, while the mutation of the PPxY site in the intracellular tail (SUSD4-ΔPY mutant) abrogated binding of NEDD4 only partially, mutation of the LPxY site (SUSD4-ΔLY mutant) or of both sites (SUSD4-ΔPY/LY mutant) completely prevented the binding to NEDD4 ubiquitin ligases (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). These mutations did not change significantly the level of HA-SUSD4 protein in transfected HEK293 cells suggesting that the degradation of SUSD4 itself is not regulated by binding of NEDD4 ubiquitin ligases (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). In accordance with our results obtained using SEP-GluA2 as a bait (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), GluA2 was detected in extracts obtained by affinity purification of the HA-tagged full-length SUSD4 (HA-SUSD4), while it was absent if HA-SUSD4 was replaced by a control transmembrane protein, PVRL3α (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Deletion of the extracellular domain (HA-SUSD4ΔN<sub>T</sub>) or the cytoplasmic domain (HA-SUSD4ΔC<sub>T</sub>) did not reduce significantly the ability to interact with SEP-GluA2 when compared to HA-SUSD4 (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Strong co-immunoprecipitation of GluA2 was detected in anti-HA affinity-purified extracts from cells expressing the HA-tagged extracellular domain of SUSD4 alone (HA-SUSD4-N<sub>T</sub> construct), showing that this domain is sufficient for GluA2 interaction (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Finally using the SUSD4-ΔLY mutant or SUSD4-ΔPY/LY mutant as a bait did not significantly modify the levels of co-immunoprecipitated GluA2 compared to HA-SUSD4, showing that binding of NEDD4 ubiquitin ligases does not affect SUSD4’s ability to interact with GluA2.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study shows that the CCP domain-containing protein SUSD4 starts to be expressed in various neurons of the mammalian central nervous system when synapses are formed and mature. <italic>Susd4</italic> loss-of-function in mice leads to impaired motor coordination adaptation and learning, misregulation of synaptic plasticity in cerebellar PCs, and perturbed degradation of GluA2-containing AMPA receptors after chemically induced LTD. SUSD4 and the GluA2 AMPA receptor subunit interact in transfected heterologous cells and colocalize partially in transduced cultured neurons. Finally, we show that SUSD4 directly binds to ubiquitin ligases of the NEDD4 family, which have been previously shown to regulate GluA2 degradation.</p><sec id="s3-1"><title>SUSD4 promotes long-term synaptic depression</title><p>The choice between recycling of AMPA receptors to the membrane or targeting to the endolysosomal compartment for degradation is key for the regulation of the number of AMPA receptors at synapses, as well as for the direction and degree of activity-dependent synaptic plasticity (<xref ref-type="bibr" rid="bib27">Ehlers, 2000</xref>; <xref ref-type="bibr" rid="bib54">Lee et al., 2002</xref>). Blocking the trafficking of AMPA receptors through recycling endosomes, for example, using a RAB11 mutant, prevents LTP in neurons (<xref ref-type="bibr" rid="bib67">Park et al., 2004</xref>). Conversely, blocking the sorting of AMPA receptors to the endolysosomal compartment, for example, using a RAB7 mutant, impairs LTD in hippocampal CA1 pyramidal neurons and cerebellar PCs (<xref ref-type="bibr" rid="bib29">Fernández-Monreal et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Kim et al., 2017</xref>). Further support for the role of receptor degradation comes from mathematical modeling showing that in cerebellar PCs LTD depends on the regulation of the total pool of glutamate receptors (<xref ref-type="bibr" rid="bib51">Kim et al., 2017</xref>). The GluA2 AMPA receptor subunit, and its regulation, is of particular importance for LTD (<xref ref-type="bibr" rid="bib26">Diering and Huganir, 2018</xref>). Phosphorylation in its C-terminal tail and the binding of molecular partners such as PICK1 and GRIP1/2 are known to regulate endocytosis and recycling (<xref ref-type="bibr" rid="bib5">Bassani et al., 2012</xref>; <xref ref-type="bibr" rid="bib14">Chiu et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Fiuza et al., 2017</xref>), and mutations in some of the phosphorylation sites lead to impaired LTD (<xref ref-type="bibr" rid="bib16">Chung et al., 2003</xref>). The molecular partners regulating the targeting for degradation of GluA2 subunits in an activity-dependent manner during LTD remain to be identified. Our study shows that loss-of-function of <italic>Susd4</italic> leads both to loss of LTD and loss of activity-dependent degradation of GluA2 subunits. Loss-of-function of <italic>Susd4</italic> does not affect degradation of another postsynaptic receptor, GluD2, showing the specificity of SUSD4 action. Furthermore, loss-of-function of <italic>Susd4</italic> facilitates LTP of PF/PC synapses. Overall our results suggest a role for SUSD4 in the targeting of GluA2-containing AMPA receptors to the degradation compartment during synaptic plasticity.</p></sec><sec id="s3-2"><title>SUSD4 interacts with regulators of AMPA receptor turnover</title><p>The degradation of specific targets such as neurotransmitter receptors must be regulated in a stimulus-dependent and synapse-specific manner in neurons, to ensure proper long-term synaptic plasticity, learning, and memory (<xref ref-type="bibr" rid="bib85">Tai and Schuman, 2008</xref>). How is this level of specificity achieved? Adaptor proteins, such as GRASP1, GRIP1, PICK1, and NSF, are known to promote AMPA receptor recycling and LTP (<xref ref-type="bibr" rid="bib1">Anggono and Huganir, 2012</xref>). Such adaptors for the promotion of LTD remain to be found.</p><p>Our results show that SUSD4 directly binds to HECT E3 ubiquitin ligases of the NEDD4 family. The family of HECT E3 ubiquitin ligases contains 28 enzymes including the NEDD4 subfamily that is characterized by an N-terminal C2 domain, several WW domains, and the catalytic HECT domain (<xref ref-type="bibr" rid="bib93">Weber et al., 2019</xref>). This subgroup of E3 ligases adds K63 ubiquitin chains to their substrate, a modification that promotes sorting to the endolysosomal compartment for degradation (<xref ref-type="bibr" rid="bib9">Boase and Kumar, 2015</xref>). NEDD4 E3 ligases are highly expressed in neurons in the mammalian brain and have many known substrates with various functions, including ion channels and the GluA1 AMPA receptor subunit. Accordingly, KO mice for the <italic>Nedd4-1</italic> gene die during late gestation (<xref ref-type="bibr" rid="bib49">Kawabe et al., 2010</xref>). The activity and substrate selectivity of NEDD4 E3 ligases thus need to be finely tuned. Both GluA1 and GluA2 AMPA receptor subunits are ubiquitinated on lysine residues in their intracellular tails in an activity-dependent manner (<xref ref-type="bibr" rid="bib59">Lin et al., 2011</xref>; <xref ref-type="bibr" rid="bib60">Lussier et al., 2011</xref>; <xref ref-type="bibr" rid="bib76">Schwarz et al., 2010</xref>; <xref ref-type="bibr" rid="bib94">Widagdo et al., 2015</xref>). Mutation of these lysine residues decreases localization of GluA1 and GluA2 AMPA receptor subunits in the endolysosomal compartment in neurons (<xref ref-type="bibr" rid="bib94">Widagdo et al., 2015</xref>). However, GluA1 and GluA2 subunits lack any obvious intracellular direct binding motif to the WW domain of NEDD4 ubiquitin ligases, raising questions about the precise mechanism allowing regulation of AMPA subunits trafficking and degradation by these enzymes. We showed that SUSD4 and GluA2 AMPA receptor subunits interact in cells and partially colocalize in neurons. SUSD4 could thus regulate the targeting of NEDD4 ubiquitin ligases to AMPA receptors in an activity-dependent manner in neurons. Alternatively, the interaction of SUSD4 with NEDD4 ubiquitin ligases might regulate the trafficking of the SUSD4/GluA2 complex to the degradation pathway. Furthermore, among the potential partners of SUSD4 identified by our proteomics analysis, several other candidates have functions that are relevant for the regulation of synaptic plasticity, such as receptor anchoring, clathrin-mediated endocytosis, and proteasome function (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Further work is needed to determine the precise mechanism of action of SUSD4 in neurons in the context of synaptic plasticity.</p></sec><sec id="s3-3"><title>SUSD4 and neurodevelopmental disorders</title><p><italic>Susd4</italic> loss-of-function leads to motor impairments, a symptom that is also found in ASD patients (<xref ref-type="bibr" rid="bib31">Fournier et al., 2010</xref>). Deficits in LTD such as the one found in the <italic>Susd4</italic> KO mice are a common feature of several mouse models of ASDs (<xref ref-type="bibr" rid="bib3">Auerbach et al., 2011</xref>; <xref ref-type="bibr" rid="bib6">Baudouin et al., 2012</xref>; <xref ref-type="bibr" rid="bib69">Piochon et al., 2014</xref>). Because of the broad expression of SUSD4 and of ubiquitin ligases of the NEDD4 subfamily in the mammalian central nervous system, whether motor impairments in the <italic>Susd4</italic> KO mice are directly the results of synaptic deficits in cerebellar PCs remain to be demonstrated. Very recently, a reduction in exploratory behavior, in addition to impairments of motor coordination, was reported after <italic>Susd4</italic> loss-of-function (<xref ref-type="bibr" rid="bib98">Zhu et al., 2020</xref>). Thus, mutations in the <italic>Susd4</italic> gene might contribute to the etiology of neurodevelopmental disorders by impairing synaptic plasticity at many synapse types.</p><p>In humans, the 1q41-42 deletion syndrome is characterized by many symptoms including IDs and seizures, and in a high majority of the cases, the microdeletion encompasses the <italic>SUSD4</italic> gene (<xref ref-type="bibr" rid="bib72">Rosenfeld et al., 2011</xref>). A <italic>SUSD4</italic> copy number variation has been identified in a patient with ASD (<xref ref-type="bibr" rid="bib25">Cuscó et al., 2009</xref>). <italic>SUSD4</italic> was recently identified among the 124 genes with genome-wide significance for de novo mutations in a cohort of more than 10,000 patients with ASD or IDs (<xref ref-type="bibr" rid="bib17">Coe et al., 2019</xref>). The <italic>GRIA2</italic> gene (coding for the GluA2 subunit) has been found as an ASD susceptibility gene (<xref ref-type="bibr" rid="bib73">Salpietro et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Satterstrom et al., 2020</xref>), and mutations or misregulation of ubiquitin ligases have been found in many models of ASDs or IDs (<xref ref-type="bibr" rid="bib13">Cheon et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Satterstrom et al., 2020</xref>). For example, ubiquitination of GluA1 by NEDD4-2 is impaired in neurons from a model of Fragile X syndrome (<xref ref-type="bibr" rid="bib56">Lee et al., 2018</xref>). Understanding the molecular mechanism linking activity-dependent degradation of GluA2 and the SUSD4/NEDD4 complex will thus be of particular importance for our understanding of the etiology of these neurodevelopmental disorders.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Gene (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Susd4</italic></td><td valign="top">NCBI</td><td valign="top">Gene ID: 96935</td><td valign="top">chr1:182,764,895–182,896,591</td></tr><tr><td valign="top">Strain (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Susd4</italic> knockout mice</td><td valign="top">Lexicon Genetics Incorporated, <xref ref-type="bibr" rid="bib86">Tang et al., 2010</xref></td><td valign="top">B6:129S5-Susd4<sup>tm1Lex</sup></td><td valign="top"/></tr><tr><td valign="top">Strain (<italic>Mus musculus</italic>)</td><td valign="top">Htr5b-GFP mouse line</td><td valign="top">Gene Expression Nervous System Atlas (GENSAT) Project</td><td valign="top">STOCK Tg(Htr5b-EGFP)BZ265Gsat/Mmmh</td><td valign="top"/></tr><tr><td valign="top">Strain (<italic>Mus musculus</italic>)</td><td valign="top">L7Cre mouse line</td><td valign="top">Jackson Laboratories</td><td valign="top">B6.129-Tg(Pcp2-cre)2Mpin/J</td><td valign="top">Stock number 004146</td></tr><tr><td valign="top">Cell line (<italic>Homo sapiens</italic>)</td><td valign="top">HEK293H</td><td valign="top">Gibco</td><td valign="top">Cat# 11631–017</td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>Homo sapiens</italic>)</td><td valign="top">HeLA</td><td valign="top">Sigma</td><td valign="top">Cat# 93021013</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-CABP</td><td valign="top">Swant</td><td valign="top">Cat# 300</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-CABP</td><td valign="top">Swant</td><td valign="top">Cat# CB38</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-GFP</td><td valign="top">Abcam</td><td valign="top">Cat# ab1218</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-GFP</td><td valign="top">Abcam</td><td valign="top">Cat# ab6556</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-GLUA2, clone 6C4</td><td valign="top">Millipore and <break/>BD</td><td valign="top">Cat# MAB397 <break/>and <break/>Cat# 556341</td><td valign="top">(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-GLUA2</td><td valign="top">Abcam</td><td valign="top">Cat# ab206293</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-GLURδ1/2</td><td valign="top">Millipore</td><td valign="top">Cat# AB2285</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat monoclonal anti-HA</td><td valign="top">Roche Life</td><td valign="top">Cat# 11867423001</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-ITCH</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat# 12117</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-NEDD4</td><td valign="top">Millipore</td><td valign="top">Cat# 07–049</td><td valign="top">(1:100,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Guinea pig polyclonal anti-VGLUT1</td><td valign="top">Millipore</td><td valign="top">Cat# AB5905</td><td valign="top">(1:5000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Guinea pig polyclonal anti-VGLUT2</td><td valign="top">Millipore</td><td valign="top">Cat# AB2251</td><td valign="top">(1:5000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-WWP1</td><td valign="top">Proteintech</td><td valign="top">Cat# 13587–1-AP</td><td valign="top">(1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Donkey polyclonal anti-goat Alexa Fluor 568</td><td valign="top">Invitrogen</td><td valign="top">Cat# A11057</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Donkey anti-mouse Alexa Fluor 488</td><td valign="top">Invitrogen</td><td valign="top">Cat# R37114</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Donkey polyclonal anti-mouse Alexa Fluor 568</td><td valign="top">Invitrogen</td><td valign="top">#A10037</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Donkey polyclonal anti-rabbit Alexa Fluor 488</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21206</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Donkey polyclonal anti-rat Alexa Fluor 594</td><td valign="top">Invitrogen</td><td valign="top">#A21209</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Donkey polyclonal anti-rat Alexa Fluor 568</td><td valign="top">Abcam</td><td valign="top">Cat# 175475</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat polyclonal anti-guinea Pig Alexa Fluor 488</td><td valign="top">Invitrogen</td><td valign="top">Cat# A110-73</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat polyclonal anti-guinea Pig Alexa Fluor 647</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21450</td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat polyclonal anti-mouse HRP</td><td valign="top">Jackson Immune Research Laboratories</td><td valign="top">Cat# 115-035-174</td><td valign="top">(1:10,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat polyclonal anti-rat HRP</td><td valign="top">Jackson Immune Research Laboratories</td><td valign="top">#112-035-175</td><td valign="top">(1:10,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Sheep polyclonal anti-digoxigenin alkaline phosphatase</td><td valign="top">Roche Life Science</td><td valign="top">Cat# 11093274910</td><td valign="top">(1:2000 - 1:5000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-βACTIN HRP, clone AC-15</td><td valign="top">Abcam</td><td valign="top">Cat# ab49900</td><td valign="top">(1:25,000)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pHA-SUSD4-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">From pEGFP-N1 (Addgene, Cat# 6085–1)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pHA-SUSD4</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pHA-SUSD4-ΔN<sub>T</sub></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pHA-SUSD4-N<sub>T</sub></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">HA-SUSD4-ΔPY</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">HA-SUSD4-ΔLY</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">HA-SUSD4-ΔPY/LY</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pIRES2-eGFP</td><td valign="top">Addgene</td><td valign="top">Cat# 6029–1</td><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pCAG-PVRL3α</td><td valign="top">This paper</td><td valign="top"/><td valign="top">From pCAG-mGFP (Addgene, Cat# 14757)</td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">Susd4_WT_F</td><td valign="top">This paper</td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CTG TGG TTT CAA CTG GCG CTG TG</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">Susd4_WT_R</td><td valign="top">This paper</td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">GCT GCC GGT GGG TGT GCG AAC CTA</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">Susd4_KO_F</td><td valign="top">This paper</td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">TTG GCG GTT TCG CTA AAT AC</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">Susd4_KO_R</td><td valign="top">This paper</td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">GGA GCT CGT TAT CGC TAT GAC</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">Htr5b-GFP_F</td><td valign="top"/><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">TTG GCG CGC CTC CAA CAG GAT GTT AAC AAC</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">Htr5b-GFP_R</td><td valign="top"/><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CGC CCT CGC CGG ACA CGC TGA AC</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">L7cre_1</td><td valign="top"/><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">GGT GAC GGT CAG TAA ATT GGA C</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">L7cre_2</td><td valign="top"/><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CAC TTC TGA CTT GCA CTT TCC TTG G</named-content></td></tr><tr><td valign="top">Sequenced-based reagent</td><td valign="top">L7cre_3</td><td valign="top"/><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">TTC TTC AAG CTG CCC AGC AGA GAG C</named-content></td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Picrotoxin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# P1675</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">D-AP5</td><td valign="top">Tocris</td><td valign="top">Cat# 0106</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">CGP52432</td><td valign="top">Tocris</td><td valign="top">Cat# 1246</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">JNJ16259685</td><td valign="top">Tocris</td><td valign="top">Cat# 2333</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">DPCPX</td><td valign="top">Tocris</td><td valign="top">Cat# 0439</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">AM251</td><td valign="top">Tocris</td><td valign="top">Cat# 1117</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Sinaptiqs</td><td valign="top">Antoine Valera</td><td valign="top">Software written in Python</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://synaptiqs.wixsite.com/synaptiqs">http://synaptiqs.wixsite.com/synaptiqs</ext-link></td></tr><tr><td valign="top">Other</td><td valign="top">Hoechst 33342</td><td valign="top">Sigma</td><td valign="top">Cat# 14533</td><td valign="top"/></tr><tr><td valign="top">Recombinant viral particles</td><td valign="top">hSYN-DIO-HA-SUSD4-2A-eGFP-WPRE</td><td valign="top">Vector biolabs</td><td valign="top">AAV2 particles</td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>Susd4 KO mice were generated using ﻿129S5/SvEvBrd ES microinjected in C57BL/6J blastocysts and maintained on the C57BL/6J background (generated by Lexicon Genetics Incorporated, The Woodlands, TX) (<xref ref-type="bibr" rid="bib86">Tang et al., 2010</xref>). Out of the eight <italic>Susd4</italic> exons, coding exon 1 (NCBI accession NM_144796.2) and the 5'UTR (NCBI accession BM944003) were targeted by homologous recombination. This resulted in the deletion of a 1.3 kb sequence spanning the transcription initiation site and exon 1 (<xref ref-type="fig" rid="fig1">Figure 1E</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Subsequent genotyping of mice was performed using PCR to detect the WT allele (forward primer: 5' <named-content content-type="sequence">CTG TGG TTT CAA CTG GCG CTG TG</named-content> 3'; reverse primer: 5' <named-content content-type="sequence">GCT GCC GGT GGG TGT GCG AAC CTA</named-content> 3') or the targeted allele (forward primer: 5' <named-content content-type="sequence">TTG GCG GTT TCG CTA AAT AC</named-content> 3'; reverse primer: 5' <named-content content-type="sequence">GGA GCT CGT TAT CGC TAT GAC</named-content> 3'). Heterozygous <italic>Susd4</italic><sup>+/-</sup> mice were bred to obtain all the genotypes needed for the experiments (<italic>Susd4</italic><sup>+/+</sup>[WT] and <italic>Susd4</italic><sup>-/-</sup>[KO] mice) as littermates.</p><p>The Htr5b-GFP mouse line was used for labeling of CFs (The Gene Expression Nervous System Atlas [GENSAT] Project, NINDS Contracts N01NS02331 and HHSN271200723701C to The Rockefeller University [New York, NY]). Genotyping was performed using the following primers: 5' <named-content content-type="sequence">TTG GCG CGC CTC CAA CAG GAT GTT AAC AAC</named-content> 3' and 5' <named-content content-type="sequence">CGC CCT CGC CGG ACA CGC TGA AC</named-content> 3'.</p><p>The L7Cre mouse line was obtained from Jackson laboratories (B6.129-Tg(Pcp2-cre)2Mpin/J; Stock Number: 004146) and genotyping was performed using the following primers: 5' <named-content content-type="sequence">GGT GAC GGT CAG TAA ATT GGA C</named-content> 3', 5' <named-content content-type="sequence">CAC TTC TGA CTT GCA CTT TCC TTG G</named-content> 3', and 5' <named-content content-type="sequence">TTC TTC AAG CTG CCC AGC AGA GAG C</named-content> 3'.</p><p>All animal protocols were approved by the <italic>Comité Regional d’Ethique en Experimentation Animale</italic> (no. 00057.01) and animals were housed in authorized facilities of the CIRB (# C75 05 12).</p></sec><sec id="s4-2"><title>Antibodies</title><p>The following primary antibodies were used: mouse monoclonal anti-CABP (1:1000; Swant, Switzerland, Cat#300), rabbit polyclonal anti-CABP (1:1000; Swant, Cat#CB38), mouse monoclonal anti-GFP (1:1000; Abcam, Cambridge, UK, Cat#ab1218), rabbit polyclonal anti-GFP (1:1000; Abcam, Cat#ab6556), mouse monoclonal anti-GluA2 (clone 6C4; 1:500; Millipore, MA, Cat#MAB397 and BD, NJ, Cat#556341), rabbit monoclonal anti-GluA2 (1:1000; Abcam, Cat#ab206293), rabbit polyclonal anti-GluRδ1/2 (1:1000; Millipore, Cat#AB2285), rat monoclonal anti-HA (1:1000; Roche Life Science, Penzberg, Germany, Cat#11867423001), rabbit monoclonal anti-ITCH (1:1000; Cell Signaling Technology, MA, Cat#12117), rabbit polyclonal anti-NEDD4 (1:10,000; Millipore, Cat#07–049), guinea pig polyclonal anti-VGLUT1 (1:5000; Millipore, Cat#AB5905), guinea pig polyclonal anti-VGLUT2 (1:5000; Millipore, Cat#AB2251), and rabbit polyclonal anti-WWP1 (1:2000; Proteintech, Chicago, IL, Cat#13587–1-AP).</p><p>The following secondary antibodies were used: donkey polyclonal anti-goat Alexa Fluor 568 (1:1000; Invitrogen, CA, Cat#A11057), donkey anti-mouse Alexa Fluor 488 (1:1000; Invitrogen, Cat#R37114), donkey polyclonal anti-mouse Alexa Fluor 568 (1:1000; Invitrogen, #A10037), donkey polyclonal anti-rabbit Alexa Fluor 488 (1:1000; Invitrogen, Cat#A21206), donkey polyclonal anti-rat Alexa Fluor 594 (1:1000; Invitrogen, #A21209), donkey polyclonal anti-Rat Alexa Fluor 568 (1:1000; Abcam, Cat#175475), goat polyclonal anti-guinea Pig Alexa Fluor 488 (1:1000; Invitrogen, Cat#A110-73), goat polyclonal anti-guinea pig Alexa Fluor 647 (1:1000; Invitrogen, Cat#A21450), goat polyclonal anti-mouse HRP (1:10000; Jackson Immune Research Laboratories, PA, Cat#115-035-174), goat polyclonal anti-rat HRP (1:10,000; Jackson Immune Research Laboratories, #112-035-175), and mouse polyclonal anti-rabbit HRP (1:10,000; Jackson Immune Research Laboratories, #211-032-171).</p><p>The following conjugated antibodies were used: sheep polyclonal anti-digoxigenin alkaline phosphatase (1:2000-1:5000; Roche Life Science, Cat#11093274910), mouse monoclonal anti-βACTIN (clone AC-15) HRP (1:25000; Abcam, Cat#ab49900).</p></sec><sec id="s4-3"><title>Plasmids</title><p>Full-length <italic>Susd4</italic> mouse gene was cloned into the mammalian expression vector pEGFP-N1 (Addgene, MA, Cat#6085–1) to express a SUSD4-GFP fusion construct under the control of the CMV promoter (pSUSD4-GFP). An N-terminal HA tag was inserted just after the signal peptide (pHA-SUSD4-GFP). pHA-SUSD4 was obtained by removal of the C-terminal GFP of pHA-SUSD4-GFP. A truncated form of <italic>Susd4</italic>, expressing the HA-SUSD4-ΔC<sub>T</sub> mutant, was obtained by inserting a stop codon downstream of the sixth exon, 39 bp after the transmembrane domain using PCR on the pHA-SUSD4-GFP plasmid and the following primers: forward primer 5' <named-content content-type="sequence">GCG CTA GCG ATG TAT CCT TAT GAT GTT CCT G</named-content> 3'; reverse primer 5'<named-content content-type="sequence">TAG CGG CCG CTA TTA GGG GGG GAA GTG GGC CTT</named-content> 3'. Other mutant constructs were similarly obtained: the truncated form of HA-SUSD4-ΔN<sub>T</sub> corresponding to amino acids 294–490 and the extracellular form of SUSD4, HA-SUSD4-N<sub>T</sub>, corresponding to amino acids 2–299. The HA-SUSD4-ΔPY contains a mutation in amino acids 411 and 414 changing PPAY to APAA while HA-SUSD4-ΔLY is mutated in amino acids 376 and 379 changing LPTY to APTA. Mutagenesis was performed using the QuikChange Lightning Multi site directed mutagenesis kit (Agilent, Santa Clara, CA, Cat#210513) according to the manufacturer’s instructions. The plasmid pIRES2-eGFP (Addgene, Cat#6029–1) was used as transfection control. The plasmid expressing SEPGluA2 (Addgene, Cat#24001) was used to follow GluA2. The control transmembrane protein PVRL3α was cloned into the mammalian expression vector pCAG-mGFP (Addgene, Cat#14757) to express the protein under the pCAG promoter (pCAG-PVRL3α).</p></sec><sec id="s4-4"><title>Viral mediated in vivo expression of HA-SUSD4</title><p>AAV2 particles were generated using an hSYN-DIO-HA-SUSD4-2A-eGFP-WPRE construct (Vector biolabs, Malvern, PA) and injected stereotaxically in cerebella of adult mice expressing the CRE recombinase in cerebellar PCs using the L7Cre mice. In the absence of Cre expression, the transgene is not produced. In the presence of Cre expression, the transgene will be ‘FLip-EXchanged’ leading to expression of the transgene specifically in PCs.</p></sec><sec id="s4-5"><title>In situ hybridization</title><p>Fresh frozen 20-μm-thick sections were prepared using a cryostat (Cryostar NX 70, Thermo Fisher Scientific, ref: 957000H) from brains of <italic>Susd4</italic> WT and KO mice at P0, P7, or P21. The probe sequence corresponded to the nucleotide residues 287–1064 bp (encompassing exons 2–5) for mouse <italic>Susd4</italic> (NM_144796.4) cDNA. The riboprobes were used at a final concentration of 0.05 μg/μL, and hybridization was done overnight at a temperature of 72°C. The anti-digoxigenin-AP antibody (for details, see 'Antibodies' section) was used at a dilution of 1:5000. Alkaline phosphatase detection was done using BCIP/NBT colorimetric revelation (Roche Life Science, Cat#11681451001).</p></sec><sec id="s4-6"><title>Behavioral study</title><p>Twelve- to 14-week-old male mice were used in this study. They were housed in groups of 3–5 in standard conditions: 12 hr light/dark cycle, with ad libitum food and water access. Seven days before the beginning of behavioral test, mice were housed individually to limit inter-houses variability resulting from social relationships. All behavioral tests took place in the light cycle.</p><sec id="s4-6-1"><title>SHIRPA protocol</title><p>Mice performed a series of tests to ensure their general good health and motor performance and habituate them to being manipulated (<xref ref-type="bibr" rid="bib23">Crawley, 2006</xref>). The test includes observation of appearance, spontaneous behavior, neurological reflexes, anxiety, motor coordination, balance rotarod, and muscular strength tests and were performed within 5 days. Individuals presenting deficits during the SHIRPA protocol were not used for other behavioral tests.</p></sec><sec id="s4-6-2"><title>Footprint analysis</title><p>The fore and hind paws of mice were dipped in magenta and cyan non-toxic paint, respectively. Mice were allowed to walk through a rectangular plastic tunnel (9 cm W × 57 cm L × 16 cm H), whose floor was covered with a sheet of white paper. Habituation was done the day before the test. Five footsteps were considered for the analysis. Footprints were scanned and length measurements were made using ImageJ.</p></sec><sec id="s4-6-3"><title>Rotarod</title><p>Mice were first habituated to the rotarod apparatus, 3 days before the acceleration test. The habituation protocol consists of 5 min at 4 r.p.m. To evaluate the motor coordination, mice were placed on immobile rotarod cylinders, which ramped up from 0 to 45 rotations per minute in 10 min. The timer was stopped when the mouse fell off the cylinder or did a whole turn with it. For a given session, this procedure was repeated three times per day separated by 60 min. The session was repeated during 5 consecutive days.</p></sec></sec><sec id="s4-7"><title>Whole-cell patch-clamp on acute cerebellar slices</title><p>Responses to PF and CF stimulation were recorded in PCs of the lobule VI in acute parasagittal and horizontal (LTP experiments) cerebellar slices from <italic>Susd4</italic> KO juvenile (from P25 to P35) or adult (~P60) mice. <italic>Susd4</italic> WT littermates were used as controls. Mice were anesthetized using isoflurane 4% and sacrificed by decapitation. The cerebellum was dissected in ice-cold oxygenated (95% O<sub>2</sub> and 5% CO<sub>2</sub>) bicarbonate buffered solution (BBS) containing (in mM): NaCl 120, KCl 3, NaHCO<sub>3</sub> 26, NaH<sub>2</sub>PO<sub>4</sub> 1.25, CaCl<sub>2</sub> 2, MgCl<sub>2</sub> 1, and D(+)-glucose 35. Three-hundred-micrometer-thick cerebellar slices were cut with a vibratome (Microm HM650V: Thermo Scientific Microm, MA, or 7000smz-2 Campden Instruments Ltd., UK) in slicing solution (in mM): <italic>N</italic>-methyl-D-glucamine 93, KCl 2.5, NaH<sub>2</sub>PO<sub>4</sub> 1.2, NaHCO<sub>3</sub> 30, HEPES 20, D(+)-glucose 25, MgCl<sub>2</sub> 10, sodium ascorbate 5, thiourea 2, sodium pyruvate 3, <italic>N</italic>-acetyl-cystein 1, kynurenic acid 1, and CaCl<sub>2</sub> 0.5 (pH 7.3). Immediately after cutting, slices were allowed to briefly recover at 37°C in the oxygenated sucrose-based buffer (in mM): sucrose 230, KCl 2.5, NaHCO<sub>3</sub> 26, NaH<sub>2</sub>PO<sub>4</sub> 1.25, D(+)-glucose 25, CaCl<sub>2</sub> 0.8, and MgCl<sub>2</sub> 8. D-APV and minocycline at a final concentration of 50 μM and 50 nM, respectively, were added to the sucrose-based buffer. Slices were allowed to fully recover in bubbled BBS with 50 mM minocycline at 37°C for at least 40 min before starting the experiment, then maintained at room temperature for a maximum time of 8 hr (from slicing time). Patch-clamp borosilicate glass pipettes with 3–6 MΩ resistance were filled with the following internal solutions:</p><list list-type="order"><list-item><p>Cesium metanesulfonate solution (CsMe solution, for EPSC elicited from CF and PF), containing (in mM): CsMeSO<sub>3</sub> 135, NaCl 6, MgCl<sub>2</sub> 1, HEPES 10, MgATP 4, Na<sub>2</sub>GTP 0.4, EGTA 1.5, QX314Cl 5, TEA 5, and biocytin 2.6 (pH 7.3).</p></list-item><list-item><p>CsMe S-solution (for delayed EPSC quanta events), containing (in mM): CsMeSO<sub>3</sub> 140, MgCl<sub>2</sub> 0.5, HEPES 10, MgATP 4, Na<sub>2</sub>GTP 0.5, BAPTA 10, and neurobiotin 1% (pH 7.35).</p></list-item><list-item><p>Potassium gluconate solution (KGlu solution, for PF long-term plasticity), containing (in mM): K gluconate 136, KCl 10, HEPES 10, MgCl<sub>2</sub> 1, sucrose 16, MgATP 4, and Na<sub>2</sub>GTP 0.4 (pH 7.35).</p></list-item></list><p>Stimulation electrodes with ~5 MΩ resistances were pulled from borosilicate glass pipettes and filled with BBS. Recordings were performed at room temperature on slices continuously perfused with oxygenated BBS. The experiment started at least 20 min after the whole-cell configuration was established. The Digitimer DS3 (Digitimer Ltd) stimulator was used to elicit CF and PF and neuronal connectivity responses in PCs. Patch-clamp experiments were conducted in voltage clamp mode (except for the LTP and LTD induction protocols that were made under current-clamp mode) using a MultiClamp 700B amplifier (Molecular Devices, CA) and acquired using the freeware WinWCP written by John Dempster (<ext-link ext-link-type="uri" xlink:href="https://pureportal.strath.ac.uk/en/datasets/strathclyde-electrophysiology-software-winwcp-winedr">https://pureportal.strath.ac.uk/en/datasets/strathclyde-electrophysiology-software-winwcp-winedr</ext-link>). Series resistance was compensated by 60–100% and cells were discarded if significant changes were detected. Currents were low-pass filtered at 2.2 kHz and digitized at 20 kHz.</p><sec id="s4-7-1"><title>CF- and PF-EPSC experiments</title><p>To isolate the AMPARs current, the BBS was supplemented with (in mM): picrotoxin 0.1, D-AP5 10, CGP52432 0.001, JNJ16259685 0.002, DPCPX 0.0005, and AM251 0.001. CF and PF EPSCs were monitored at a holding potential of −10 mV. During CF recordings, the stimulation electrode was placed in the granule cell layer below the clamped cell; CF-mediated responses were identified by the typical all-or-none response and strong depression displayed by the second response elicited during paired-pulse stimulations (20 Hz). The number of CFs innervating the recorded PC was estimated from the number of discrete CF-EPSC steps. PF stimulation was achieved by placing the stimulation electrode in the molecular layer at the minimum distance required to avoid direct stimulation of the dendritic tree of the recorded PC. The input-output curve was obtained by incrementally increasing the stimulation strength. Peak EPSC values for PF were obtained following averaging of three consecutive recordings, values for CF EPSC correspond to the first recording. Short-term plasticity experiments were analyzed using a software written in Python by Antoine Valera (<ext-link ext-link-type="uri" xlink:href="http://synaptiqs.wixsite.com/synaptiqs">http://synaptiqs.wixsite.com/synaptiqs</ext-link>).</p></sec><sec id="s4-7-2"><title>PF long-term plasticity experiments</title><p>PCs were clamped at −60 mV. Each PF-induced response was monitored by a test protocol of paired stimulation pulses (20 Hz) applied every 20 s. A baseline was established during 10 min of paired-pulse stimulation in the voltage clamp configuration. After that, an induction protocol was applied in current-clamp mode with cells held at −60 mV. During LTD induction, the PFs were stimulated with two pulses at high frequency (200 Hz) and, after 100 ms, the CF was stimulated with four pulses at high frequency (200 Hz) repeated every 2 s for a period of 10 min. During LTP induction, recordings were made using BBS not supplemented with picrotoxin, and the PFs were stimulated with bursts of 15 pulses at high frequency (100 Hz) repeated every 3 s for a period of 5 min (<xref ref-type="bibr" rid="bib7">Binda et al., 2016</xref>). Then, PCs were switched to the voltage clamp mode and paired stimulation pulses applied again, lasting 40 min. All the data were normalized to the mean baseline. Long-term plasticity was analyzed with the software Igor Pro 6.05 (WaveMetrics INC, OR).</p><p>PF- and CF-delayed EPSC quanta events were detected and analyzed using the software Clampfit 10.7 (Molecular Devices). PF- and CF-delayed EPSC quanta superposed events were discarded manually based on the waveform. A threshold of 10 pA for minimal amplitude was used to select the CF events; 100 (PF) and 300 (CF) events for each neuron were studied by analyzing consecutive traces.</p></sec></sec><sec id="s4-8"><title>High-density MEA analysis of PC spiking in acute cerebellar slices</title><p>Experiments were performed on acute cerebellar slices obtained from 3- to 6-month-old mice in artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl 125, KCl 2.5, D(+)glucose 25, NaHCO<sub>3</sub> 25, NaH<sub>2</sub>PO<sub>4</sub> 1.25, CaCl<sub>2</sub> 2, and MgCl<sub>2</sub> 1 (95% O<sub>2</sub> and 5% CO<sub>2</sub>). Parasagittal slices (320 μm) were cut at 30°C (<xref ref-type="bibr" rid="bib41">Huang and Uusisaari, 2013</xref>) with a vibratome (7000smz-2, Campden Instruments Ltd.) at an advance speed of 0.03 mm/s and vertical vibration set to 0.1–0.3 μm. Slices were then transferred to a chamber filled with oxygenated ACSF at 37°C and allowed to recover for 1 hr before recordings.</p><p>For recording, the slices were placed over a high-density microelectrode array of 4096 electrodes (electrode size, 21 × 21 μm; pitch, 42 μm; 64 × 64 matrix; Biocam X, 3Brain, Wädenswil, Switzerland) and constantly perfused with oxygenated ACSF at 37°C. Extracellular activity was digitized at 17 kHz and data were analyzed with the Brainwave software (3Brain). The signal was filtered with a Butterworth high-pass filter at 200 Hz, spikes were detected with a hard threshold set at −100 µV, and unsupervised spike sorting was done by the software. We selected units with a firing rate between 15 and 100 spikes per second and we excluded units presenting more than 5% of refractory period violation (set to 3 ms). Recordings were performed on two slices per animal, each slice containing between 20 and 200 active neurons, and results were then pooled for each animal.</p><p>To quantify the average variability in the firing rate, the CV of the ISI in seconds was calculated as the ratio of the standard deviation of ISIs to the mean ISI of a given cell. To measure the firing pattern variability within a short period of two ISIs, CV2 was calculated [CV2 = 2|ISI<sub>n+1</sub> − ISI<sub>n</sub>|/(ISI<sub>n+1</sub> + ISI<sub>n</sub>)] (<xref ref-type="bibr" rid="bib40">Holt and Douglas, 1996</xref>).</p></sec><sec id="s4-9"><title>Affinity purification of SUSD4 interactors from synaptosome preparations</title><p>HEK293H (Gibco, MA, Cat#11631–017) were maintained at 37°C in a humidified incubator with 5% CO<sub>2</sub> in Dulbecco’s modified Eagle’s medium (DMEM; containing high glucose and glutamax, Life Technologies, Cat#31966047) supplemented with 10% fetal bovine serum (FBS, Gibco, Cat#16141–079) and 1% penicillin/streptomycin (Gibco, Cat#15140122). 10<sup>6</sup> cells were plated per well in a six-well plate and transfected 24 hr (h) after plating with the indicated plasmids (1 µg plasmid DNA per well) using Lipofectamine 2000 (Invitrogen, Cat#11668–019) according to manufacturer’s instructions.</p><p>Forty-eight hours after transfection, cells were lysed and proteins were solubilized for 1 hr at 4°C under gentle rotation in lysis buffer (10 mM Tris-HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, 1% Triton X100 [Tx; Sigma, Cat#x100], 0.1% SDS) supplemented with a protease inhibitor cocktail (1:100; Sigma, Cat#P8340) and MG132 (100 µM; Sigma, Cat#C2211). Lysates were sonicated for 10 s, further solubilized for 1 hr at 4°C and clarified by centrifugation at 6000 r.p.m. during 8 min (min). Supernatants were collected, incubated with 5 µg of rat monoclonal anti-HA antibody (for details, see 'Antibodies' section), together with 60 µL of protein G-sepharose beads (Sigma; Cat#10003D) for 3 hr at 4°C, to coat the beads with the HA-tagged SUSD4 proteins. When SUSD4-GFP was expressed for affinity pull downs, GFP-Trap was done according to the instructions of GFP-Trap_A (Chromotek, NY, Cat#ABIN509397). Coated beads were washed three times with 1 mL lysis buffer.</p><p>To prepare synaptosome fractions, cerebella from WT mice (P30) were homogenized at 4°C in 10 volumes (w/v) of 10 mM Tris buffer (pH 7.4) containing 0.32 M sucrose and protease inhibitor cocktail (1:100). The resulting homogenate was centrifuged at 800 g for 5 min at 4°C to remove nuclei and cellular debris. Synaptosomal fractions were purified by centrifugation for 20 min at 20,000 r.p.m. (SW41Ti rotor) at 4°C using Percoll-sucrose density gradients (2-6-10–20%; v/v). Each fraction from the 10–20% interface was collected and washed in 10 mL of a 5 mM HEPES buffer pH 7.4 (NaOH) containing 140 mM NaCl, 3 mM KCl, 1.2 mM MgSO<sub>4</sub>, 1.2 mM CaCl<sub>2</sub>, 1 mM NaH<sub>2</sub>PO<sub>4</sub>, 5 mM NaHCO<sub>3</sub>, and 10 mM D(+)-glucose by centrifugation. The suspension was immediately centrifuged at 10,000 g at 4°C for 10 min. Synaptosomes in the pellet were resuspended in 100 µL of lysis buffer (10 mM Tris-HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, 1% Tx) supplemented with a protease inhibitor cocktail (1:100) and MG132 (100 µM). Lysates were sonicated for 10 s and further incubated for 1 hr at 4°C. HA-SUSD4, GFP-SUSD4, or its control GFP-coated beads were then incubated with the synaptosomal lysates for 3 hr at 4°C. Beads were washed three times with lysis buffer supplemented with 0.1% SDS. Bound proteins were eluted for 10 min at 75°C using Laemmli buffer (160 mM Tris pH 6.8, 4% SDS, 20% glycerol, 0.008% BBP) with 5% β-mercaptoethanol before SDS-PAGE followed by western blotting or mass spectrometry.</p></sec><sec id="s4-10"><title>Co-immunoprecipitation experiments in HEK293 cells</title><p>10<sup>6</sup> HEK293H cells were plated per well in six-well plates and transfected 24 hr after plating with the indicated plasmids (1.6 µg plasmid SEPGluA2 per well, using a molar ratio of 2:1 SEPGluA2:other plasmid) using Lipofectamine 2000 according to manufacturer’s instructions. For anti-HA pull downs, proteins from HEK293 cell lysates were solubilized in lysis buffer (1 M Tris-HCl pH 8, 10 mM EDTA, 1.5 M NaCl, 1% Tergitol [Sigma; Cat#NP40], 2% Na azide, 10% SDS, and 10% Na deoxycholate) supplemented with a protease inhibitor cocktail (1:100) and MG132 (1%). Then, lysates were sonicated for 15 s, further clarified by a centrifugation at 14,000 r.p.m. for 10 min. Supernatants were collected and incubated with Dynabeads Protein G (Life Technologies, Cat#10004D) and 28.8 µg of rat monoclonal anti-HA antibody (for details, see 'Antibodies' section) under gentle rotation for 1 hr at 4°C. Precipitates were washed three times in lysis buffer and then eluted by boiling (65°C) the beads 15 min in sample buffer (made from sample buffer 2× concentrate, Sigma, Cat#S3401) before SDS-PAGE. For SEPGluA2 pull downs, 48 hr after transfection, cells were washed twice in 1× PBS, lysed with 200 µL of lysis buffer (50 mM Tris-HCl pH 8% and 1% Tx) supplemented with a protease inhibitor cocktail (1:100) and MG132 (50 µM), scraped, sonicated 3 × 5 s, and proteins were further solubilized for 30 min at 4°C under rotation. Lysates were clarified by centrifugation at 14,000 r.p.m. for 10 min at 4°C. Supernatants (inputs) were collected and incubated with G-protein Dynabeads (Thermo Fisher Scientific, Cat#10004D), previously linked to mouse anti-GFP antibody (for details, see 'Antibodies' section), under gentle rotation for 1 hr at 4°C, to coat the beads with the SEP-tagged GluA2 proteins and interactors. Using a magnet, coated beads were washed five times in lysis buffer and bound proteins were then eluted by boiling for 15 min at 65°C in 1× sample buffer before SDS-PAGE and western blot analysis for detection of HA-SUSD4, GluA2, and PVRL3α.</p></sec><sec id="s4-11"><title>Mass spectrometry analysis</title><p>Proteins were separated by SDS-PAGE on 10% polyacrylamide gels (Mini-PROTEAN TGX Precast Gels, Bio-Rad, Hercules, CA) and stained with Protein Staining Solution (Euromedex, Souffelweyersheim, France). Gel lanes were cut into five pieces and destained with 50 mM triethylammonium bicarbonate and three washes in 100% acetonitrile. Proteins were digested in-gel using trypsin (1.2 µg/band, Gold, Promega, Madison, WI), as previously described (<xref ref-type="bibr" rid="bib87">Thouvenot et al., 2008</xref>). Digest products were dehydrated in a vacuum centrifuge.</p><sec id="s4-11-1"><title>Nano-flow LC-MS/MS</title><p>Peptides, resuspended in 3 μL formic acid (0.1%, buffer A), were loaded onto a 15 cm reversed phase column (75 mm inner diameter, Acclaim Pepmap 100 C18, Thermo Fisher Scientific) and separated with an Ultimate 3000 RSLC system (Thermo Fisher Scientific) coupled to a Q Exactive Plus (Thermo Fisher Scientific) via a nano-electrospray source, using a 120 min gradient of 5-40% of buffer B (80% ACN, 0.1% formic acid) and a flow rate of 300 nL/min.</p><p>MS/MS analyses were performed in a data-dependent mode. Full scans (375–1500 m/z) were acquired in the Orbitrap mass analyzer with a 70,000 resolution at 200 m/z. For the full scans, 3 × 10<sup>6</sup> ions were accumulated within a maximum injection time of 60 ms and detected in the Orbitrap analyzer. The 12 most intense ions with charge states ≥2 were sequentially isolated to a target value of 1 × 10<sup>5</sup> with a maximum injection time of 45 ms and fragmented by higher-energy collisional dissociation in the collision cell (normalized collision energy of 28%) and detected in the Orbitrap analyzer at 17,500 resolution.</p></sec><sec id="s4-11-2"><title>MS/MS data analysis</title><p>Raw spectra were processed using the MaxQuant environment (<xref ref-type="bibr" rid="bib22">Cox and Mann, 2008</xref>, v1.5.5.1) and Andromeda for database search (<xref ref-type="bibr" rid="bib21">Cox et al., 2011</xref>). The MS/MS spectra were matched against the UniProt Reference proteome (Proteome ID UP000000589) of <italic>Mus musculus</italic> (release 2017_03; <ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org">http://www.uniprot.org</ext-link>) and 250 frequently observed contaminants (MaxQuant contaminants database) as well as reversed sequences of all entries. The following settings were applied for database interrogation: mass tolerance of 7 ppm (MS) and 0.5 Th (MS/MS), trypsin/P enzyme specificity, up to two missed cleavages allowed, only peptides with at least seven amino acids in length considered, and Oxidation (Met) and acetylation (protein N-term) as variable modifications. The ‘match between runs’ feature was allowed, with a matching time window of 0.7 min. False discovery rate (FDR) was set at 0.01 for peptides and proteins.</p><p>A representative protein ID in each protein group was automatically selected using an in-house bioinformatics tool (leading v2.1). First, proteins with the most numerous identified peptides are isolated in a ‘match group’ (proteins from the ‘Protein IDs’ column with the maximum number of ‘peptides counts’). When more than one protein ID is present after filtering in a ‘match group’, the best annotated protein in UniProtKB (reviewed entries rather than automatic ones), highest evidence for protein existence, most annotated protein according to the number of Gene Ontology Annotations (GOA Mouse v151) is defined as the ‘leading’ protein. Only proteins identified with a minimum of two unique peptides, without MS/MS in control immunoprecipitation and exhibiting more than fourfold enrichment (assessed by spectral count ratio) in Sushi domain-containing protein 4 (SUSD4) immunoprecipitation vs. control immunoprecipitation, in the two biological replicates, were considered as potential partners of SUSD4 (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s4-11-3"><title>GO analysis</title><p>The statistically enriched GO categories for the 28 candidate proteins were determined by Cytoscape (v3.6) plugin ClueGO v2.5.3 (<xref ref-type="bibr" rid="bib8">Bindea et al., 2009</xref>). The molecular function category was considered (release 18.12.2018, <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/GOA">https://www.ebi.ac.uk/GOA</ext-link>), except evidences inferred from electronic annotations. Terms are selected by different filter criteria from the ontology source: three to eight GO level intervals, minimum of four genes per GO term, and 10% of associated genes/term. A two-sided hypergeometric test for enrichment analysis (Benjamini-Hochberg standard correction used for multiple testing) was applied against the whole identified protein as reference set. Other predefined settings were used. Each node representing a specific GO term is color-coded based on enrichment significance (p-value). Edge thickness represents the calculated score (κ) to determine the association strength between the terms.</p></sec></sec><sec id="s4-12"><title>cLTD and GluA2 surface biotinylation assay in cerebellar acute slices</title><p>Three-hundred-micrometer-thick parasagittal cerebellar slices were obtained from P31-P69 WT and <italic>Susd4</italic> KO mice following the same protocol described before (see 'Whole-cell patch-clamp on acute cerebellar slices' section). Slices were incubated for 2 hr at 37°C in oxygenated BBS with or without proteasome (50 µM MG132 in DMSO) and lysosomal (100 µg/mL leupeptine in water, Sigma, Cat#11034626001) inhibitors. cLTD was induced by incubating the slices for 5 min at 37°C in BBS containing 50 mM K<sup>+</sup> and 10 μM glutamate (diluted in HCl), followed by a recovery period in BBS for 30 min at 37°C all under oxygenation, in presence or not of inhibitors. Control slices were incubated in parallel in BBS solution containing HCl. Slices were then homogenized in lysis buffer, containing: 50 mM Tris-HCl, 150 mM NaCl, 0.1% SDS, 0.02% Na azide, 0.5% Na deoxycholate, 1% NP-40, and protease inhibitor cocktail (1:100). Homogenates were incubated 45 min at 4°C, then sonicated and centrifuged at 14,000 r.p.m. for 10 min at 4°C. Supernatants were then heated at 65°C in 2× sample buffer (Sigma, Cat#S3401) prior to western blot analysis for detection of GluA2 and GluD2.</p><p>For GluA2 surface biotinylation assay, cerebellar slices (obtained from mice aged between P27 and P61) were treated as above. After a recovery period of 30 min at 37°C in BBS, slices were incubated in a biotinylation solution (Thermo Fisher Scientific, EZ-Link Sulfo-NHS-SS-Biotin, Cat#A39258, 0.125 mg/mL) for 30 min on ice without oxygen. Slices were finally washed three times for 10 min in PBS pH 7.4 at 4°C and then homogenized in lysis buffer, containing: 50 mM Tris-HCl pH 8, 150 mM NaCl, 0.1% SDS, 0.02% Na azide, 0.5% Na deoxycholate, 1% NP-40, and protease inhibitor cocktail (1:100). Homogenates were incubated 45 min at 4°C, then sonicated and centrifuged at 14,000 r.p.m. for 10 min at 4°C. Supernatants (inputs) were collected and incubated with Dynabeads MyOne Streptavidin C1 (Thermo Fisher Scientific, Cat#65001) under gentle rotation overnight at 4°C. Using a magnet, beads were washed five times in lysis buffer and biotinylated proteins were then eluted by boiling for 15 min at 65°C in 1× sample buffer before SDS-PAGE and western blot analysis for detection of GluA2.</p></sec><sec id="s4-13"><title>Immunocytochemistry</title><p>Labeling of primary hippocampal neurons: Hippocampi were dissected from E18 mice embryos and dissociated. 1.2×10<sup>5</sup> neurons were plated onto 18 mm diameter glass coverslips precoated with 80 µg/mL poly-L-ornithine (Sigma, Cat#P3655) and maintained at 37°C in a 5% CO<sub>2</sub> humidified incubator in neurobasal medium (Gibco, Cat#21103049) supplemented with 2% B-27 supplement (Gibco, Cat#17504044) and 2 mM Glutamax (Gibco, Cat#35050-038). Fresh culture medium (neurobasal medium supplemented with 2% B-27, 2 mM L-glutamine [Gibco, Cat#A2916801], and 5% horse serum [Gibco, Cat#26050088]) was added every week for maintenance of the neuronal cultures.</p><p>Hippocampal neurons at days in vitro 13 (DIV13) were transfected using Lipofectamine 2000 and 0.5 µg plasmid DNA per well. After transfection, neurons were maintained in the incubator for 24 hr, then fixed with 100% methanol for 10 min at −20°C. After rinsing with PBS, non-specific binding sites were blocked using PBS containing 4% donkey serum (DS, Abcam, Cat#ab7475) and 0.2% Tx primary and secondary antibodies were diluted in PBS 1% DS/0.2% Tx and incubated 1 hr at room temperature. Three washes in PBS 0.2% Tx were performed before and after each antibody incubation. Nuclear counterstaining was performed with Hoechst 33342 (Sigma, Cat#14533) for 15 min at room temperature.</p><p>Labeling of primary cerebellar mixed cultures: Cerebellar mixed cultures were prepared from P0 tg/0 ‘B6.129-Tg(Pcp2-cre)2Mpin/J’ (stock number 004146, outbred, C57Bl/6J background) mouse cerebella and were dissected and dissociated according to previously published protocol (<xref ref-type="bibr" rid="bib84">Tabata et al., 2000</xref>). Neurons were seeded at a density of 5×10<sup>6</sup> cells/mL. Mixed cerebellar cultures were transduced at DIV3 using a Cre-dependent AAV construct that expresses HA-tagged SUSD4 and soluble GFP (2 µL of AAV2-hSYN-DIO-HA-SUSD4-2A-eGFP-WPRE at 4.1×10<sup>12</sup> GC/mL or control AAV2-hSYN-DIO-eGFP-WPRE at 5×10<sup>12</sup> GC/mL). At DIV17, neurons were fixed with 4% PFA in PBS 1× for 30 min at room temperature. After rinsing with PBS, non-specific binding sites were blocked using PBS containing 4% DS and 0.2% Tx. Primary and secondary antibodies were diluted in PBS 1% DS and 0.2% Tx and incubated 1 hr at room temperature. Three PBS 0.2% Tx washes were performed before and after each antibody incubation. Nuclear counterstaining was performed with Hoechst 33342 for 15 min at room temperature.</p></sec><sec id="s4-14"><title>Immunohistochemistry</title><sec id="s4-14-1"><title>Labeling of brain sections</title><p>Thirty-micrometer-thick parasagittal brain sections were obtained using a freezing microtome (SM2010R, Leica) and brains obtained after intracardiac perfusion with 4% PFA in PBS solution of mice sedated with 100 mg/kg pentobarbital sodium. Sections were then washed three times for 5 min in PBS, then blocked with PBS 4% DS for 30 min. The primary antibodies were diluted in PBS, 1% DS, 1% Tx. The sections were incubated in the primary antibody solution overnight at 4°C and then washed three times for 5 min in PBS 1% Tx. Sections were incubated in the secondary antibody, diluted in PBS, 1% DS, 1% Tx solution for 1 hr at room temperature. The sections were then incubated for 15 min at room temperature with the nuclear marker Hoechst 33342 in PBS 0.2% Tx. Finally, the sections were washed three times for 5 min in PBS 1% Tx, recovered in PBS and mounted with Prolong Gold (Thermo Fisher Scientific, Cat#P36934) between microscope slides and coverslips (Menzel-gläser, Brunswick, Germany, Cat#15165252).</p></sec></sec><sec id="s4-15"><title>RT-PCR and quantitative RT-PCR</title><p>For standard RT-PCR, total RNA was isolated from the cortex, cerebellum, and brainstem of 2-month-old <italic>Susd4</italic> KO mice and WT control littermates, using the RNeasy mini kit (Qiagen, Venlo, The Netherlands, Cat#74104). Equivalent amounts of total RNA (100 ng) were reverse-transcribed according to the protocol of SuperScript VILO cDNA Synthesis kit (Life Technologies, CA, Cat#11754–250) as stated by manufacturer’s instructions. The primers used were forward 5' TGT TAC TGC TCG TCA TCC TGG 3' and reverse 5' GAG AGT CCC CTC TGC ACT TGG 3’. PCR was performed with an annealing temperature of 61°C, for 39 cycles, using the manufacturer’s instructions (<italic>Taq</italic> polymerase; New England Biolabs, MA, Cat#M0273S). Quantitative PCR was performed using the TaqMan universal master mix II with UNG (Applied Biosystems, Cat# 4440038) and the following TaqMan probes: <italic>Rpl13a</italic> (#4331182_Mm01612986_gH) and <italic>Susd4</italic> (#4331182_Mm01312134_m1).</p></sec><sec id="s4-16"><title>Western blot analysis</title><p>After samples were mixed with sample buffer, proteins were resolved by electrophoresis on a 4–12% NuPAGE Bis-Tris-Gel according to Invitrogen protocols, then electrotransferred using TransBlot DS Semi-dry transfer Cell or TransBlot Turbo transfer system (Bio-Rad) to PVDF membrane (Immobilon-P transfer membrane, Millipore, Cat#IPVH00010). Membranes were blocked in PBS supplemented with Tween 0.2% (PBST) and non-fat milk 5% and incubated with primary antibodies in PBST-milk 5%. After washing three times in PBST, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies in PBST-milk 5%. Membranes were finally washed three times and bound antibodies were revealed using Immobilon Western (Millipore, Cat#WBKLS) or Western Femto Maximum Sensitivity (Thermo Fisher Scientific, Cat#34095) or SuperSignal West Dura (Thermo Fisher Scientific, Cat#34075) or ECL western blotting substrate (Thermo Fisher Scientific, Cat#32209) chemiluminescent solutions and images acquired on a Fusion FX7 system (Vilber Lourmat, Île-de-France, France). Quantitation of western blots was performed using the ImageJ software on raw images under non-saturating conditions. Band intensities of proteins of interest were obtained after manually selecting a rectangular region around the band. The signal intensity of the band of interest was then normalized to the signal intensity of the corresponding βACTIN (used as a loading control). For quantifications of immunoprecipitation experiments, input intensities were normalized to βACTIN, and then the intensities of immunoprecipitated protein bands were normalized to the normalized inputs, unless otherwise stated.</p></sec><sec id="s4-17"><title>Image acquisition and quantification</title><p>In situ hybridization images were acquired using an Axio Zoom v16 (Zeiss, Oberkochen, Germany) microscope equipped with a digital camera (AxioCam HRm) using a 10× objective (pixel size 0.650 μm).</p><p>Immunofluorescence image stacks were acquired using a confocal microscope (SP5, Leica), using a 63× objective (1.4 NA, oil immersion, pixel size: 57 nm for cell culture imaging, pixel size: 228 nm for 63×; 76 nm, 57 nm, 45 nm for higher magnifications for in vivo imaging). The pinhole aperture was set to 1 airy unit and a z-step of 200 nm was used. Laser intensity and photomultiplier tube gain was set so as to occupy the full dynamic range of the detector. Images were acquired in 16-bit range. Immunofluorescence images and image stacks from <xref ref-type="fig" rid="fig1">Figures 1C, D</xref> and <xref ref-type="fig" rid="fig4">4F</xref> were acquired using a Zeiss LSM 980 Confocal with an Airyscan detector (v2.0), using a 63× objective (1.4 NA, oil immersion, pixel size: 43 nm, z-step of 150 nm).</p><p>Deconvolution was performed for the VGLUT1 images with Huygens 4.1 software (Scientific Volume Imaging) using maximum likelihood estimation algorithm from Matlab. Forty iterations were applied in classical mode, background intensity was averaged from the voxels with lowest intensity, and signal-to-noise ratio values were set to a value of 25.</p><p>VGLUT1 and VGLUT2 puncta were analyzed using the Matlab software and a homemade code source (Dr. Andréa Dumoulin). The number, area, and intensity of puncta were quantified using the mask of each puncta generated by the Multidimensional Image Analysis software from Metamorph (Molecular Devices). For each animal, puncta parameters were measured from four equidistant images within a 35-image stack at 160 nm interval, acquired from three different lobules (n = 12).</p><p>The software ImageJ was used to measure the total area of a cerebellar section from images of staining obtained with the nuclear marker Hoechst. The extension of the molecular layer was measured using images of the anti-CABP staining. Nine parasagittal sections were analyzed per animal. The data presented correspond to the mean per animal.</p></sec><sec id="s4-18"><title>Statistical analysis</title><p>Data from all experiments were imported in Prism (GraphPad Software, CA) for statistical analysis, except for electrophysiology data that were imported to Igor Pro 6.05 (WaveMetrics INC) for statistical analysis.</p><p>In the case of two column analyses of means, the differences between the two groups were assessed using two-tailed Student’s t-test. Normality of populations was assessed using D’Agostino and Pearson, Shapiro-Wilk, and Kolmogorov-Smirnov normality tests. When groups did not fit the normal distribution, the non-parametric Mann-Whitney test was used. For the rotarod behavioral test (two variables, genotype and trial), two-way repeated measures ANOVA followed by Bonferroni post hoc test was performed. The two-tailed Student’s one sample t-test (when normality criterion was met) or the two-tailed Wilcoxon signed rank test was used to compare ratios to a null hypothesis of 1 for biochemical experiments or 100 for long-term plasticity (<xref ref-type="bibr" rid="bib28">Fay, 2013</xref>). Differences in cumulative probability were assessed with the Kolmogorov-Smirnov distribution test, and differences in distribution were tested using the chi-squared test.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We gratefully acknowledge the Collège de France imaging facility (IMACHEM-IBiSA), in particular P Mailly for help with the design of the macro for GluA2 quantification and Estelle Anceaume for help with image acquisition. We also thank the personnel from the CIRB, INCI, and chronobiotron CNRS UMS 3415, IBPS, and IBENS animal facilities. We would like to thank Philippe Marin for advice on proteomics analysis. Mass spectrometry experiments were carried out using facilities of the Functional Proteomics Platform of Montpellier.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con6"><p>Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Validation, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con11"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con12"><p>Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con13"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Resources</p></fn><fn fn-type="con" id="con15"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con16"><p>Resources</p></fn><fn fn-type="con" id="con17"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con18"><p>Funding acquisition, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con19"><p>Resources, Software, Supervision, Funding acquisition, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con20"><p>Conceptualization, Resources, Software, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: All animal protocols were approved by the Comité Regional d'Ethique en Experimentation Animale (no. 00057.01) and animals were housed in authorized facilities of the CIRB (# C75 05 12).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Behavioral characterization of <italic>Susd4 </italic>KO mice.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65712-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-65712-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anggono</surname> <given-names>V</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of AMPA receptor trafficking and synaptic plasticity</article-title><source>Current Opinion in Neurobiology</source><volume>22</volume><fpage>461</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2011.12.006</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atluri</surname> <given-names>PP</given-names></name><name><surname>Regehr</surname> <given-names>WG</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Determinants of the time course of facilitation at the granule cell to purkinje cell synapse</article-title><source>The Journal of Neuroscience</source><volume>16</volume><fpage>5661</fpage><lpage>5671</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-18-05661.1996</pub-id><pub-id pub-id-type="pmid">8795622</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbach</surname> <given-names>BD</given-names></name><name><surname>Osterweil</surname> <given-names>EK</given-names></name><name><surname>Bear</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mutations causing syndromic autism define an Axis of synaptic pathophysiology</article-title><source>Nature</source><volume>480</volume><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/nature10658</pub-id><pub-id pub-id-type="pmid">22113615</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badura</surname> <given-names>A</given-names></name><name><surname>Verpeut</surname> <given-names>JL</given-names></name><name><surname>Metzger</surname> <given-names>JW</given-names></name><name><surname>Pereira</surname> <given-names>TD</given-names></name><name><surname>Pisano</surname> <given-names>TJ</given-names></name><name><surname>Deverett</surname> <given-names>B</given-names></name><name><surname>Bakshinskaya</surname> <given-names>DE</given-names></name><name><surname>Wang</surname> <given-names>SS-H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Normal cognitive and social development require posterior cerebellar activity</article-title><source>eLife</source><volume>7</volume><elocation-id>e36401</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.36401</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassani</surname> <given-names>S</given-names></name><name><surname>Cingolani</surname> <given-names>LA</given-names></name><name><surname>Valnegri</surname> <given-names>P</given-names></name><name><surname>Folci</surname> <given-names>A</given-names></name><name><surname>Zapata</surname> <given-names>J</given-names></name><name><surname>Gianfelice</surname> <given-names>A</given-names></name><name><surname>Sala</surname> <given-names>C</given-names></name><name><surname>Goda</surname> <given-names>Y</given-names></name><name><surname>Passafaro</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The X-Linked intellectual disability protein TSPAN7 regulates excitatory synapse development and AMPAR trafficking</article-title><source>Neuron</source><volume>73</volume><fpage>1143</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.01.021</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baudouin</surname> <given-names>SJ</given-names></name><name><surname>Gaudias</surname> <given-names>J</given-names></name><name><surname>Gerharz</surname> <given-names>S</given-names></name><name><surname>Hatstatt</surname> <given-names>L</given-names></name><name><surname>Zhou</surname> <given-names>K</given-names></name><name><surname>Punnakkal</surname> <given-names>P</given-names></name><name><surname>Tanaka</surname> <given-names>KF</given-names></name><name><surname>Spooren</surname> <given-names>W</given-names></name><name><surname>Hen</surname> <given-names>R</given-names></name><name><surname>De Zeeuw</surname> <given-names>CI</given-names></name><name><surname>Vogt</surname> <given-names>K</given-names></name><name><surname>Scheiffele</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism</article-title><source>Science</source><volume>338</volume><fpage>128</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1126/science.1224159</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname> <given-names>F</given-names></name><name><surname>Dorgans</surname> <given-names>K</given-names></name><name><surname>Reibel</surname> <given-names>S</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name><name><surname>Poulain</surname> <given-names>B</given-names></name><name><surname>Isope</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Inhibition promotes long-term potentiation at cerebellar excitatory synapses</article-title><source>Scientific Reports</source><volume>6</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/srep33561</pub-id><pub-id pub-id-type="pmid">27641070</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindea</surname> <given-names>G</given-names></name><name><surname>Mlecnik</surname> <given-names>B</given-names></name><name><surname>Hackl</surname> <given-names>H</given-names></name><name><surname>Charoentong</surname> <given-names>P</given-names></name><name><surname>Tosolini</surname> <given-names>M</given-names></name><name><surname>Kirilovsky</surname> <given-names>A</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>Pagès</surname> <given-names>F</given-names></name><name><surname>Trajanoski</surname> <given-names>Z</given-names></name><name><surname>Galon</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1091</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp101</pub-id><pub-id pub-id-type="pmid">19237447</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boase</surname> <given-names>NA</given-names></name><name><surname>Kumar</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NEDD4: the founding member of a family of ubiquitin-protein ligases</article-title><source>Gene</source><volume>557</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2014.12.020</pub-id><pub-id pub-id-type="pmid">25527121</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolliger</surname> <given-names>MF</given-names></name><name><surname>Martinelli</surname> <given-names>DC</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins</article-title><source>PNAS</source><volume>108</volume><fpage>2534</fpage><lpage>2539</lpage><pub-id pub-id-type="doi">10.1073/pnas.1019577108</pub-id><pub-id pub-id-type="pmid">21262840</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buitrago</surname> <given-names>MM</given-names></name><name><surname>Schulz</surname> <given-names>JB</given-names></name><name><surname>Dichgans</surname> <given-names>J</given-names></name><name><surname>Luft</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Short and long-term motor skill learning in an accelerated rotarod training paradigm</article-title><source>Neurobiology of Learning and Memory</source><volume>81</volume><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.nlm.2004.01.001</pub-id><pub-id pub-id-type="pmid">15082022</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Jiang</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Dempsey</surname> <given-names>DR</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Devreotes</surname> <given-names>P</given-names></name><name><surname>Wolberger</surname> <given-names>C</given-names></name><name><surname>Amzel</surname> <given-names>LM</given-names></name><name><surname>Gabelli</surname> <given-names>SB</given-names></name><name><surname>Cole</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A tunable Brake for HECT ubiquitin ligases</article-title><source>Molecular Cell</source><volume>66</volume><fpage>345</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.03.020</pub-id><pub-id pub-id-type="pmid">28475870</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheon</surname> <given-names>S</given-names></name><name><surname>Dean</surname> <given-names>M</given-names></name><name><surname>Chahrour</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The ubiquitin proteasome pathway in neuropsychiatric disorders</article-title><source>Neurobiology of Learning and Memory</source><volume>16</volume><elocation-id>106791</elocation-id><pub-id pub-id-type="doi">10.1016/j.nlm.2018.01.012</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname> <given-names>SL</given-names></name><name><surname>Diering</surname> <given-names>GH</given-names></name><name><surname>Ye</surname> <given-names>B</given-names></name><name><surname>Takamiya</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>CM</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Niranjan</surname> <given-names>T</given-names></name><name><surname>Schwartz</surname> <given-names>CE</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>GRASP1 regulates synaptic plasticity and learning through endosomal recycling of AMPA receptors</article-title><source>Neuron</source><volume>93</volume><fpage>1405</fpage><lpage>1419</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.031</pub-id><pub-id pub-id-type="pmid">28285821</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choquet</surname> <given-names>D</given-names></name><name><surname>Triller</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The dynamic synapse</article-title><source>Neuron</source><volume>80</volume><fpage>691</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.013</pub-id><pub-id pub-id-type="pmid">24183020</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>HJ</given-names></name><name><surname>Steinberg</surname> <given-names>JP</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name><name><surname>Linden</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression</article-title><source>Science</source><volume>300</volume><fpage>1751</fpage><lpage>1755</lpage><pub-id pub-id-type="doi">10.1126/science.1082915</pub-id><pub-id pub-id-type="pmid">12805550</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coe</surname> <given-names>BP</given-names></name><name><surname>Stessman</surname> <given-names>HAF</given-names></name><name><surname>Sulovari</surname> <given-names>A</given-names></name><name><surname>Geisheker</surname> <given-names>MR</given-names></name><name><surname>Bakken</surname> <given-names>TE</given-names></name><name><surname>Lake</surname> <given-names>AM</given-names></name><name><surname>Dougherty</surname> <given-names>JD</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Hormozdiari</surname> <given-names>F</given-names></name><name><surname>Bernier</surname> <given-names>RA</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity</article-title><source>Nature Genetics</source><volume>51</volume><fpage>106</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0288-4</pub-id><pub-id pub-id-type="pmid">30559488</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coesmans</surname> <given-names>M</given-names></name><name><surname>Weber</surname> <given-names>JT</given-names></name><name><surname>De Zeeuw</surname> <given-names>CI</given-names></name><name><surname>Hansel</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Bidirectional parallel fiber plasticity in the cerebellum under climbing fiber control</article-title><source>Neuron</source><volume>44</volume><fpage>691</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.10.031</pub-id><pub-id pub-id-type="pmid">15541316</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collingridge</surname> <given-names>GL</given-names></name><name><surname>Peineau</surname> <given-names>S</given-names></name><name><surname>Howland</surname> <given-names>JG</given-names></name><name><surname>Wang</surname> <given-names>YT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Long-term depression in the CNS</article-title><source>Nature Reviews Neuroscience</source><volume>11</volume><fpage>459</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1038/nrn2867</pub-id><pub-id pub-id-type="pmid">20559335</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname> <given-names>Q</given-names></name><name><surname>Soteros</surname> <given-names>BM</given-names></name><name><surname>Wollet</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>JH</given-names></name><name><surname>Sia</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>1067</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-0672-0</pub-id><pub-id pub-id-type="pmid">32661396</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Neuhauser</surname> <given-names>N</given-names></name><name><surname>Michalski</surname> <given-names>A</given-names></name><name><surname>Scheltema</surname> <given-names>RA</given-names></name><name><surname>Olsen</surname> <given-names>JV</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Andromeda: a peptide search engine integrated into the MaxQuant environment</article-title><source>Journal of Proteome Research</source><volume>10</volume><fpage>1794</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.1021/pr101065j</pub-id><pub-id pub-id-type="pmid">21254760</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id><pub-id pub-id-type="pmid">19029910</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Crawley</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2006">2006</year><source>What’s Wrong with My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice</source><publisher-name>John Wiley &amp; Sons, Inc</publisher-name><pub-id pub-id-type="doi">10.1002/0470119055</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crepel</surname> <given-names>F</given-names></name><name><surname>Mariani</surname> <given-names>J</given-names></name><name><surname>Delhaye-Bouchaud</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Evidence for a multiple innervation of purkinje cells by climbing fibers in the immature rat cerebellum</article-title><source>Journal of Neurobiology</source><volume>7</volume><fpage>567</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1002/neu.480070609</pub-id><pub-id pub-id-type="pmid">1003202</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuscó</surname> <given-names>I</given-names></name><name><surname>Medrano</surname> <given-names>A</given-names></name><name><surname>Gener</surname> <given-names>B</given-names></name><name><surname>Vilardell</surname> <given-names>M</given-names></name><name><surname>Gallastegui</surname> <given-names>F</given-names></name><name><surname>Villa</surname> <given-names>O</given-names></name><name><surname>González</surname> <given-names>E</given-names></name><name><surname>Rodríguez-Santiago</surname> <given-names>B</given-names></name><name><surname>Vilella</surname> <given-names>E</given-names></name><name><surname>Del Campo</surname> <given-names>M</given-names></name><name><surname>Pérez-Jurado</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>1795</fpage><lpage>1804</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp092</pub-id><pub-id pub-id-type="pmid">19246517</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diering</surname> <given-names>GH</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The AMPA receptor code of synaptic plasticity</article-title><source>Neuron</source><volume>100</volume><fpage>314</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.10.018</pub-id><pub-id pub-id-type="pmid">30359599</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting</article-title><source>Neuron</source><volume>28</volume><fpage>511</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)00129-X</pub-id><pub-id pub-id-type="pmid">11144360</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fay</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2013">2013</year><source>A Biologist’s Guide to Statistical Thinking and Analysis</source><publisher-name>WormBook</publisher-name><pub-id pub-id-type="doi">10.1895/wormbook.1.159.1</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández-Monreal</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>TC</given-names></name><name><surname>Royo</surname> <given-names>M</given-names></name><name><surname>Esteban</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The balance between receptor recycling and trafficking toward lysosomes determines synaptic strength during long-term depression</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>13200</fpage><lpage>13205</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0061-12.2012</pub-id><pub-id pub-id-type="pmid">22993436</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiuza</surname> <given-names>M</given-names></name><name><surname>Rostosky</surname> <given-names>CM</given-names></name><name><surname>Parkinson</surname> <given-names>GT</given-names></name><name><surname>Bygrave</surname> <given-names>AM</given-names></name><name><surname>Halemani</surname> <given-names>N</given-names></name><name><surname>Baptista</surname> <given-names>M</given-names></name><name><surname>Milosevic</surname> <given-names>I</given-names></name><name><surname>Hanley</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PICK1 regulates AMPA receptor endocytosis via direct interactions with AP2 α-appendage and dynamin</article-title><source>Journal of Cell Biology</source><volume>216</volume><fpage>3323</fpage><lpage>3338</lpage><pub-id pub-id-type="doi">10.1083/jcb.201701034</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fournier</surname> <given-names>KA</given-names></name><name><surname>Hass</surname> <given-names>CJ</given-names></name><name><surname>Naik</surname> <given-names>SK</given-names></name><name><surname>Lodha</surname> <given-names>N</given-names></name><name><surname>Cauraugh</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Motor coordination in autism spectrum disorders: a synthesis and meta-analysis</article-title><source>Journal of Autism and Developmental Disorders</source><volume>40</volume><fpage>1227</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1007/s10803-010-0981-3</pub-id><pub-id pub-id-type="pmid">20195737</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>Z</given-names></name><name><surname>van Beugen</surname> <given-names>BJ</given-names></name><name><surname>De Zeeuw</surname> <given-names>CI</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Distributed synergistic plasticity and cerebellar learning</article-title><source>Nature Reviews Neuroscience</source><volume>13</volume><fpage>619</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1038/nrn3312</pub-id><pub-id pub-id-type="pmid">22895474</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendrel</surname> <given-names>M</given-names></name><name><surname>Rapti</surname> <given-names>G</given-names></name><name><surname>Richmond</surname> <given-names>JE</given-names></name><name><surname>Bessereau</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A secreted complement-control-related protein ensures acetylcholine receptor clustering</article-title><source>Nature</source><volume>461</volume><fpage>992</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1038/nature08430</pub-id><pub-id pub-id-type="pmid">19794415</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotow</surname> <given-names>T</given-names></name><name><surname>Sotelo</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Postnatal development of the inferior olivary complex in the rat: iv. synaptogenesis of GABAergic afferents, analyzed by glutamic acid decarboxylase immunocytochemistry</article-title><source>The Journal of Comparative Neurology</source><volume>263</volume><fpage>526</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1002/cne.902630406</pub-id><pub-id pub-id-type="pmid">3667987</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez-Castellanos</surname> <given-names>N</given-names></name><name><surname>Da Silva-Matos</surname> <given-names>CM</given-names></name><name><surname>Zhou</surname> <given-names>K</given-names></name><name><surname>Canto</surname> <given-names>CB</given-names></name><name><surname>Renner</surname> <given-names>MC</given-names></name><name><surname>Koene</surname> <given-names>LMC</given-names></name><name><surname>Ozyildirim</surname> <given-names>O</given-names></name><name><surname>Sprengel</surname> <given-names>R</given-names></name><name><surname>Kessels</surname> <given-names>HW</given-names></name><name><surname>De Zeeuw</surname> <given-names>CI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Motor learning requires purkinje cell synaptic potentiation through activation of AMPA-Receptor subunit GluA3</article-title><source>Neuron</source><volume>93</volume><fpage>409</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.046</pub-id><pub-id pub-id-type="pmid">28103481</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname> <given-names>K</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Functional differentiation of multiple climbing fiber inputs during synapse elimination in the developing cerebellum</article-title><source>Neuron</source><volume>38</volume><fpage>785</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(03)00298-8</pub-id><pub-id pub-id-type="pmid">12797962</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname> <given-names>H</given-names></name><name><surname>Pang</surname> <given-names>Z</given-names></name><name><surname>Bao</surname> <given-names>D</given-names></name><name><surname>Miyazaki</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Miura</surname> <given-names>E</given-names></name><name><surname>Parris</surname> <given-names>J</given-names></name><name><surname>Rong</surname> <given-names>Y</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Yuzaki</surname> <given-names>M</given-names></name><name><surname>Morgan</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cbln1 is essential for synaptic integrity and plasticity in the cerebellum</article-title><source>Nature Neuroscience</source><volume>8</volume><fpage>1534</fpage><lpage>1541</lpage><pub-id pub-id-type="doi">10.1038/nn1576</pub-id><pub-id pub-id-type="pmid">16234806</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Regulation and interaction of multiple types of synaptic plasticity in a purkinje neuron and their contribution to motor learning</article-title><source>The Cerebellum</source><volume>17</volume><fpage>756</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1007/s12311-018-0963-0</pub-id><pub-id pub-id-type="pmid">29995220</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmquist</surname> <given-names>E</given-names></name><name><surname>Okroj</surname> <given-names>M</given-names></name><name><surname>Nodin</surname> <given-names>B</given-names></name><name><surname>Jirström</surname> <given-names>K</given-names></name><name><surname>Blom</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sushi domain‐containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase</article-title><source>The FASEB Journal</source><volume>27</volume><fpage>2355</fpage><lpage>2366</lpage><pub-id pub-id-type="doi">10.1096/fj.12-222042</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname> <given-names>GR</given-names></name><name><surname>Douglas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Comparison of discharge variability visual cortex neurons</article-title><source>Journal of Neurophysiology</source><volume>75</volume><fpage>1806</fpage><lpage>1814</lpage></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Uusisaari</surname> <given-names>MY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Elevated temperature during slicing enhances acute slice preparation quality</article-title><source>Frontiers in Cellular Neuroscience</source><volume>7</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3389/fncel.2013.00048</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichise</surname> <given-names>T</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name><name><surname>Hashimoto</surname> <given-names>K</given-names></name><name><surname>Yanagihara</surname> <given-names>D</given-names></name><name><surname>Nakao</surname> <given-names>K</given-names></name><name><surname>Shigemoto</surname> <given-names>R</given-names></name><name><surname>Katsuki</surname> <given-names>M</given-names></name><name><surname>Aiba</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>mGluR1 in cerebellar purkinje cells essential for long-term depression, synapse elimination, and motor coordination</article-title><source>Science</source><volume>288</volume><fpage>1832</fpage><lpage>1835</lpage><pub-id pub-id-type="doi">10.1126/science.288.5472.1832</pub-id><pub-id pub-id-type="pmid">10846166</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Cerebellar long-term depression: characterization, signal transduction, and functional roles</article-title><source>Physiological Reviews</source><volume>81</volume><fpage>1143</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1152/physrev.2001.81.3.1143</pub-id><pub-id pub-id-type="pmid">11427694</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cerebellar circuitry as a neuronal machine</article-title><source>Progress in Neurobiology</source><volume>78</volume><fpage>272</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2006.02.006</pub-id><pub-id pub-id-type="pmid">16759785</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>M</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Long-lasting depression of parallel fiber-Purkinje cell transmission induced by conjunctive stimulation of parallel fibers and climbing fibers in the cerebellar cortex</article-title><source>Neuroscience Letters</source><volume>33</volume><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(82)90380-9</pub-id><pub-id pub-id-type="pmid">6298664</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakegawa</surname> <given-names>W</given-names></name><name><surname>Mitakidis</surname> <given-names>N</given-names></name><name><surname>Miura</surname> <given-names>E</given-names></name><name><surname>Abe</surname> <given-names>M</given-names></name><name><surname>Matsuda</surname> <given-names>K</given-names></name><name><surname>Takeo</surname> <given-names>YH</given-names></name><name><surname>Kohda</surname> <given-names>K</given-names></name><name><surname>Motohashi</surname> <given-names>J</given-names></name><name><surname>Takahashi</surname> <given-names>A</given-names></name><name><surname>Nagao</surname> <given-names>S</given-names></name><name><surname>Muramatsu</surname> <given-names>S</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Aricescu</surname> <given-names>AR</given-names></name><name><surname>Yuzaki</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Anterograde C1ql1 signaling is required in order to determine and maintain a Single-Winner climbing fiber in the mouse cerebellum</article-title><source>Neuron</source><volume>85</volume><fpage>316</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.020</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakegawa</surname> <given-names>W</given-names></name><name><surname>Katoh</surname> <given-names>A</given-names></name><name><surname>Narumi</surname> <given-names>S</given-names></name><name><surname>Miura</surname> <given-names>E</given-names></name><name><surname>Motohashi</surname> <given-names>J</given-names></name><name><surname>Takahashi</surname> <given-names>A</given-names></name><name><surname>Kohda</surname> <given-names>K</given-names></name><name><surname>Fukazawa</surname> <given-names>Y</given-names></name><name><surname>Yuzaki</surname> <given-names>M</given-names></name><name><surname>Matsuda</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Optogenetic control of synaptic AMPA receptor endocytosis reveals roles of LTD in motor learning</article-title><source>Neuron</source><volume>99</volume><fpage>985</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.07.034</pub-id><pub-id pub-id-type="pmid">30122381</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashiwabuchi</surname> <given-names>N</given-names></name><name><surname>Ikeda</surname> <given-names>K</given-names></name><name><surname>Araki</surname> <given-names>K</given-names></name><name><surname>Hirano</surname> <given-names>T</given-names></name><name><surname>Shibuki</surname> <given-names>K</given-names></name><name><surname>Takayama</surname> <given-names>C</given-names></name><name><surname>Inoue</surname> <given-names>Y</given-names></name><name><surname>Kutsuwada</surname> <given-names>T</given-names></name><name><surname>Yagi</surname> <given-names>T</given-names></name><name><surname>Kang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Impairment of motor coordination, purkinje cell synapse formation, and cerebellar long-term depression in GluR Delta 2 mutant mice</article-title><source>Cell</source><volume>81</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90334-8</pub-id><pub-id pub-id-type="pmid">7736576</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabe</surname> <given-names>H</given-names></name><name><surname>Neeb</surname> <given-names>A</given-names></name><name><surname>Dimova</surname> <given-names>K</given-names></name><name><surname>Young</surname> <given-names>SM</given-names></name><name><surname>Takeda</surname> <given-names>M</given-names></name><name><surname>Katsurabayashi</surname> <given-names>S</given-names></name><name><surname>Mitkovski</surname> <given-names>M</given-names></name><name><surname>Malakhova</surname> <given-names>OA</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name><name><surname>Umikawa</surname> <given-names>M</given-names></name><name><surname>Kariya</surname> <given-names>K</given-names></name><name><surname>Goebbels</surname> <given-names>S</given-names></name><name><surname>Nave</surname> <given-names>KA</given-names></name><name><surname>Rosenmund</surname> <given-names>C</given-names></name><name><surname>Jahn</surname> <given-names>O</given-names></name><name><surname>Rhee</surname> <given-names>J</given-names></name><name><surname>Brose</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development</article-title><source>Neuron</source><volume>65</volume><fpage>358</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.007</pub-id><pub-id pub-id-type="pmid">20159449</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayakabe</surname> <given-names>M</given-names></name><name><surname>Kakizaki</surname> <given-names>T</given-names></name><name><surname>Kaneko</surname> <given-names>R</given-names></name><name><surname>Sasaki</surname> <given-names>A</given-names></name><name><surname>Nakazato</surname> <given-names>Y</given-names></name><name><surname>Shibasaki</surname> <given-names>K</given-names></name><name><surname>Ishizaki</surname> <given-names>Y</given-names></name><name><surname>Saito</surname> <given-names>H</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Furuya</surname> <given-names>N</given-names></name><name><surname>Yanagawa</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Motor dysfunction in cerebellar purkinje cell-specific vesicular GABA transporter knockout mice</article-title><source>Frontiers in Cellular Neuroscience</source><volume>7</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3389/fncel.2013.00286</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>T</given-names></name><name><surname>Yamamoto</surname> <given-names>Y</given-names></name><name><surname>Tanaka-Yamamoto</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Timely regulated sorting from early to late endosomes is required to maintain cerebellar long-term depression</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>e00518-3</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00518-3</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konnerth</surname> <given-names>A</given-names></name><name><surname>Llano</surname> <given-names>I</given-names></name><name><surname>Armstrong</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Synaptic currents in cerebellar purkinje cells</article-title><source>PNAS</source><volume>87</volume><fpage>2662</fpage><lpage>2665</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.7.2662</pub-id><pub-id pub-id-type="pmid">1969639</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalonde</surname> <given-names>R</given-names></name><name><surname>Strazielle</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Motor performance and regional brain metabolism of spontaneous murine mutations with cerebellar atrophy</article-title><source>Behavioural Brain Research</source><volume>125</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/S0166-4328(01)00276-5</pub-id><pub-id pub-id-type="pmid">11682101</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>YT</given-names></name><name><surname>Sheng</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Clathrin adaptor AP2 and NSF interact with overlapping sites of GluR2 and play distinct roles in AMPA receptor trafficking and hippocampal LTD</article-title><source>Neuron</source><volume>36</volume><fpage>661</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)01024-3</pub-id><pub-id pub-id-type="pmid">12441055</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Simonetta</surname> <given-names>A</given-names></name><name><surname>Sheng</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Subunit rules governing the sorting of internalized AMPA receptors in hippocampal neurons</article-title><source>Neuron</source><volume>43</volume><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.06.015</pub-id><pub-id pub-id-type="pmid">15260958</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KY</given-names></name><name><surname>Jewett</surname> <given-names>KA</given-names></name><name><surname>Chung</surname> <given-names>HJ</given-names></name><name><surname>Tsai</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>2805</fpage><lpage>2816</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy189</pub-id><pub-id pub-id-type="pmid">29771335</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefort</surname> <given-names>JM</given-names></name><name><surname>Vincent</surname> <given-names>J</given-names></name><name><surname>Tallot</surname> <given-names>L</given-names></name><name><surname>Jarlier</surname> <given-names>F</given-names></name><name><surname>De Zeeuw</surname> <given-names>CI</given-names></name><name><surname>Rondi-Reig</surname> <given-names>L</given-names></name><name><surname>Rochefort</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impaired cerebellar purkinje cell potentiation generates unstable spatial map orientation and inaccurate navigation</article-title><source>Nature Communications</source><volume>10</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41467-019-09958-5</pub-id><pub-id pub-id-type="pmid">31113954</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leto</surname> <given-names>K</given-names></name><name><surname>Arancillo</surname> <given-names>M</given-names></name><name><surname>Becker</surname> <given-names>EB</given-names></name><name><surname>Buffo</surname> <given-names>A</given-names></name><name><surname>Chiang</surname> <given-names>C</given-names></name><name><surname>Ding</surname> <given-names>B</given-names></name><name><surname>Dobyns</surname> <given-names>WB</given-names></name><name><surname>Dusart</surname> <given-names>I</given-names></name><name><surname>Haldipur</surname> <given-names>P</given-names></name><name><surname>Hatten</surname> <given-names>ME</given-names></name><name><surname>Hoshino</surname> <given-names>M</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name><name><surname>Kilpatrick</surname> <given-names>DL</given-names></name><name><surname>Koibuchi</surname> <given-names>N</given-names></name><name><surname>Marino</surname> <given-names>S</given-names></name><name><surname>Martinez</surname> <given-names>S</given-names></name><name><surname>Millen</surname> <given-names>KJ</given-names></name><name><surname>Millner</surname> <given-names>TO</given-names></name><name><surname>Miyata</surname> <given-names>T</given-names></name><name><surname>Parmigiani</surname> <given-names>E</given-names></name><name><surname>Schilling</surname> <given-names>K</given-names></name><name><surname>Sekerková</surname> <given-names>G</given-names></name><name><surname>Sillitoe</surname> <given-names>RV</given-names></name><name><surname>Sotelo</surname> <given-names>C</given-names></name><name><surname>Uesaka</surname> <given-names>N</given-names></name><name><surname>Wefers</surname> <given-names>A</given-names></name><name><surname>Wingate</surname> <given-names>RJ</given-names></name><name><surname>Hawkes</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Consensus paper: cerebellar development</article-title><source>The Cerebellum</source><volume>15</volume><fpage>789</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1007/s12311-015-0724-2</pub-id><pub-id pub-id-type="pmid">26439486</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>A</given-names></name><name><surname>Hou</surname> <given-names>Q</given-names></name><name><surname>Jarzylo</surname> <given-names>L</given-names></name><name><surname>Amato</surname> <given-names>S</given-names></name><name><surname>Gilbert</surname> <given-names>J</given-names></name><name><surname>Shang</surname> <given-names>F</given-names></name><name><surname>Man</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Nedd4-mediated AMPA receptor ubiquitination regulates receptor turnover and trafficking</article-title><source>Journal of Neurochemistry</source><volume>119</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07221.x</pub-id><pub-id pub-id-type="pmid">21338354</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname> <given-names>MP</given-names></name><name><surname>Nasu-Nishimura</surname> <given-names>Y</given-names></name><name><surname>Roche</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Activity-dependent ubiquitination of the AMPA receptor subunit GluA2</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>3077</fpage><lpage>3081</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5944-10.2011</pub-id><pub-id pub-id-type="pmid">21414928</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masugi-Tokita</surname> <given-names>M</given-names></name><name><surname>Tarusawa</surname> <given-names>E</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Molnár</surname> <given-names>E</given-names></name><name><surname>Fujimoto</surname> <given-names>K</given-names></name><name><surname>Shigemoto</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Number and density of AMPA receptors in individual synapses in the rat cerebellum as revealed by SDS-digested freeze-fracture replica labeling</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>2135</fpage><lpage>2144</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2861-06.2007</pub-id><pub-id pub-id-type="pmid">17314308</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathy</surname> <given-names>A</given-names></name><name><surname>Ho</surname> <given-names>SS</given-names></name><name><surname>Davie</surname> <given-names>JT</given-names></name><name><surname>Duguid</surname> <given-names>IC</given-names></name><name><surname>Clark</surname> <given-names>BA</given-names></name><name><surname>Häusser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Encoding of oscillations by axonal bursts in inferior olive neurons</article-title><source>Neuron</source><volume>62</volume><fpage>388</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.023</pub-id><pub-id pub-id-type="pmid">19447094</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>K</given-names></name><name><surname>Miura</surname> <given-names>E</given-names></name><name><surname>Miyazaki</surname> <given-names>T</given-names></name><name><surname>Kakegawa</surname> <given-names>W</given-names></name><name><surname>Emi</surname> <given-names>K</given-names></name><name><surname>Narumi</surname> <given-names>S</given-names></name><name><surname>Fukazawa</surname> <given-names>Y</given-names></name><name><surname>Ito-Ishida</surname> <given-names>A</given-names></name><name><surname>Kondo</surname> <given-names>T</given-names></name><name><surname>Shigemoto</surname> <given-names>R</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Yuzaki</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer</article-title><source>Science</source><volume>328</volume><fpage>363</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1126/science.1185152</pub-id><pub-id pub-id-type="pmid">20395510</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>S</given-names></name><name><surname>Kakegawa</surname> <given-names>W</given-names></name><name><surname>Budisantoso</surname> <given-names>T</given-names></name><name><surname>Nomura</surname> <given-names>T</given-names></name><name><surname>Kohda</surname> <given-names>K</given-names></name><name><surname>Yuzaki</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Stargazin regulates AMPA receptor trafficking through adaptor protein complexes during long-term depression</article-title><source>Nature Communications</source><volume>4</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/ncomms3759</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname> <given-names>M</given-names></name><name><surname>Suzuki</surname> <given-names>E</given-names></name><name><surname>Tsunoda</surname> <given-names>S</given-names></name><name><surname>Hama</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The matrix proteins hasp and hig exhibit segregated distribution within synaptic clefts and play distinct roles in synaptogenesis</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>590</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2300-15.2016</pub-id><pub-id pub-id-type="pmid">26758847</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoll</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A brief history of Long-Term potentiation</article-title><source>Neuron</source><volume>93</volume><fpage>281</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.12.015</pub-id><pub-id pub-id-type="pmid">28103477</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>M</given-names></name><name><surname>Penick</surname> <given-names>E</given-names></name><name><surname>Edwards</surname> <given-names>J</given-names></name><name><surname>Kauer</surname> <given-names>J</given-names></name><name><surname>Ehlers</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Recycling endosomes supply AMPA receptors for Long-term potentiation</article-title><source>Science</source><volume>305</volume><fpage>1972</fpage><lpage>1975</lpage><pub-id pub-id-type="doi">10.1126/science.1102026</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penn</surname> <given-names>AC</given-names></name><name><surname>Zhang</surname> <given-names>CL</given-names></name><name><surname>Georges</surname> <given-names>F</given-names></name><name><surname>Royer</surname> <given-names>L</given-names></name><name><surname>Breillat</surname> <given-names>C</given-names></name><name><surname>Hosy</surname> <given-names>E</given-names></name><name><surname>Petersen</surname> <given-names>JD</given-names></name><name><surname>Humeau</surname> <given-names>Y</given-names></name><name><surname>Choquet</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hippocampal LTP and contextual learning require surface diffusion of AMPA receptors</article-title><source>Nature</source><volume>549</volume><fpage>384</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1038/nature23658</pub-id><pub-id pub-id-type="pmid">28902836</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piochon</surname> <given-names>C</given-names></name><name><surname>Kloth</surname> <given-names>AD</given-names></name><name><surname>Grasselli</surname> <given-names>G</given-names></name><name><surname>Titley</surname> <given-names>HK</given-names></name><name><surname>Nakayama</surname> <given-names>H</given-names></name><name><surname>Hashimoto</surname> <given-names>K</given-names></name><name><surname>Wan</surname> <given-names>V</given-names></name><name><surname>Simmons</surname> <given-names>DH</given-names></name><name><surname>Eissa</surname> <given-names>T</given-names></name><name><surname>Nakatani</surname> <given-names>J</given-names></name><name><surname>Cherskov</surname> <given-names>A</given-names></name><name><surname>Miyazaki</surname> <given-names>T</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Takumi</surname> <given-names>T</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>SS-H</given-names></name><name><surname>Hansel</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cerebellar plasticity and motor learning deficits in a copy-number variation mouse model of autism</article-title><source>Nature Communications</source><volume>5</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/ncomms6586</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochefort</surname> <given-names>C</given-names></name><name><surname>Arabo</surname> <given-names>A</given-names></name><name><surname>André</surname> <given-names>M</given-names></name><name><surname>Poucet</surname> <given-names>B</given-names></name><name><surname>Save</surname> <given-names>E</given-names></name><name><surname>Rondi-Reig</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cerebellum shapes hippocampal spatial code</article-title><source>Science</source><volume>334</volume><fpage>385</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1126/science.1207403</pub-id><pub-id pub-id-type="pmid">22021859</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rondi-Reig</surname> <given-names>L</given-names></name><name><surname>Delhaye-Bouchaud</surname> <given-names>N</given-names></name><name><surname>Mariani</surname> <given-names>J</given-names></name><name><surname>Caston</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Role of the inferior olivary complex in motor skills and motor learning in the adult rat</article-title><source>Neuroscience</source><volume>77</volume><fpage>955</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(96)00518-0</pub-id><pub-id pub-id-type="pmid">9130777</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeld</surname> <given-names>JA</given-names></name><name><surname>Lacassie</surname> <given-names>Y</given-names></name><name><surname>El-Khechen</surname> <given-names>D</given-names></name><name><surname>Escobar</surname> <given-names>LF</given-names></name><name><surname>Reggin</surname> <given-names>J</given-names></name><name><surname>Heuer</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>E</given-names></name><name><surname>Jenkins</surname> <given-names>LS</given-names></name><name><surname>Collins</surname> <given-names>AT</given-names></name><name><surname>Zinner</surname> <given-names>S</given-names></name><name><surname>Babcock</surname> <given-names>M</given-names></name><name><surname>Morrow</surname> <given-names>B</given-names></name><name><surname>Schultz</surname> <given-names>RA</given-names></name><name><surname>Torchia</surname> <given-names>BS</given-names></name><name><surname>Ballif</surname> <given-names>BC</given-names></name><name><surname>Tsuchiya</surname> <given-names>KD</given-names></name><name><surname>Shaffer</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome</article-title><source>European Journal of Medical Genetics</source><volume>54</volume><fpage>42</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2010.10.002</pub-id><pub-id pub-id-type="pmid">20951845</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salpietro</surname> <given-names>V</given-names></name><name><surname>Dixon</surname> <given-names>CL</given-names></name><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Bello</surname> <given-names>OD</given-names></name><name><surname>Vandrovcova</surname> <given-names>J</given-names></name><name><surname>Efthymiou</surname> <given-names>S</given-names></name><name><surname>Maroofian</surname> <given-names>R</given-names></name><name><surname>Heimer</surname> <given-names>G</given-names></name><name><surname>Burglen</surname> <given-names>L</given-names></name><name><surname>Valence</surname> <given-names>S</given-names></name><name><surname>Torti</surname> <given-names>E</given-names></name><name><surname>Hacke</surname> <given-names>M</given-names></name><name><surname>Rankin</surname> <given-names>J</given-names></name><name><surname>Tariq</surname> <given-names>H</given-names></name><name><surname>Colin</surname> <given-names>E</given-names></name><name><surname>Procaccio</surname> <given-names>V</given-names></name><name><surname>Striano</surname> <given-names>P</given-names></name><name><surname>Mankad</surname> <given-names>K</given-names></name><name><surname>Lieb</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Pisani</surname> <given-names>L</given-names></name><name><surname>Bettencourt</surname> <given-names>C</given-names></name><name><surname>Männikkö</surname> <given-names>R</given-names></name><name><surname>Manole</surname> <given-names>A</given-names></name><name><surname>Brusco</surname> <given-names>A</given-names></name><name><surname>Grosso</surname> <given-names>E</given-names></name><name><surname>Ferrero</surname> <given-names>GB</given-names></name><name><surname>Armstrong-Moron</surname> <given-names>J</given-names></name><name><surname>Gueden</surname> <given-names>S</given-names></name><name><surname>Bar-Yosef</surname> <given-names>O</given-names></name><name><surname>Tzadok</surname> <given-names>M</given-names></name><name><surname>Monaghan</surname> <given-names>KG</given-names></name><name><surname>Santiago-Sim</surname> <given-names>T</given-names></name><name><surname>Person</surname> <given-names>RE</given-names></name><name><surname>Cho</surname> <given-names>MT</given-names></name><name><surname>Willaert</surname> <given-names>R</given-names></name><name><surname>Yoo</surname> <given-names>Y</given-names></name><name><surname>Chae</surname> <given-names>JH</given-names></name><name><surname>Quan</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Bernier</surname> <given-names>RA</given-names></name><name><surname>Xia</surname> <given-names>K</given-names></name><name><surname>Blesson</surname> <given-names>A</given-names></name><name><surname>Jain</surname> <given-names>M</given-names></name><name><surname>Motazacker</surname> <given-names>MM</given-names></name><name><surname>Jaeger</surname> <given-names>B</given-names></name><name><surname>Schneider</surname> <given-names>AL</given-names></name><name><surname>Boysen</surname> <given-names>K</given-names></name><name><surname>Muir</surname> <given-names>AM</given-names></name><name><surname>Myers</surname> <given-names>CT</given-names></name><name><surname>Gavrilova</surname> <given-names>RH</given-names></name><name><surname>Gunderson</surname> <given-names>L</given-names></name><name><surname>Schultz-Rogers</surname> <given-names>L</given-names></name><name><surname>Klee</surname> <given-names>EW</given-names></name><name><surname>Dyment</surname> <given-names>D</given-names></name><name><surname>Osmond</surname> <given-names>M</given-names></name><name><surname>Parellada</surname> <given-names>M</given-names></name><name><surname>Llorente</surname> <given-names>C</given-names></name><name><surname>Gonzalez-Peñas</surname> <given-names>J</given-names></name><name><surname>Carracedo</surname> <given-names>A</given-names></name><name><surname>Van Haeringen</surname> <given-names>A</given-names></name><name><surname>Ruivenkamp</surname> <given-names>C</given-names></name><name><surname>Nava</surname> <given-names>C</given-names></name><name><surname>Heron</surname> <given-names>D</given-names></name><name><surname>Nardello</surname> <given-names>R</given-names></name><name><surname>Iacomino</surname> <given-names>M</given-names></name><name><surname>Minetti</surname> <given-names>C</given-names></name><name><surname>Skabar</surname> <given-names>A</given-names></name><name><surname>Fabretto</surname> <given-names>A</given-names></name><name><surname>Raspall-Chaure</surname> <given-names>M</given-names></name><name><surname>Chez</surname> <given-names>M</given-names></name><name><surname>Tsai</surname> <given-names>A</given-names></name><name><surname>Fassi</surname> <given-names>E</given-names></name><name><surname>Shinawi</surname> <given-names>M</given-names></name><name><surname>Constantino</surname> <given-names>JN</given-names></name><name><surname>De Zorzi</surname> <given-names>R</given-names></name><name><surname>Fortuna</surname> <given-names>S</given-names></name><name><surname>Kok</surname> <given-names>F</given-names></name><name><surname>Keren</surname> <given-names>B</given-names></name><name><surname>Bonneau</surname> <given-names>D</given-names></name><name><surname>Choi</surname> <given-names>M</given-names></name><name><surname>Benzeev</surname> <given-names>B</given-names></name><name><surname>Zara</surname> <given-names>F</given-names></name><name><surname>Mefford</surname> <given-names>HC</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Clayton-Smith</surname> <given-names>J</given-names></name><name><surname>Macaya</surname> <given-names>A</given-names></name><name><surname>Rothman</surname> <given-names>JE</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Kullmann</surname> <given-names>DM</given-names></name><name><surname>Houlden</surname> <given-names>H</given-names></name><collab>SYNAPS Study Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3094</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10910-w</pub-id><pub-id pub-id-type="pmid">31300657</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satterstrom</surname> <given-names>FK</given-names></name><name><surname>Kosmicki</surname> <given-names>JA</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Breen</surname> <given-names>MS</given-names></name><name><surname>De Rubeis</surname> <given-names>S</given-names></name><name><surname>An</surname> <given-names>JY</given-names></name><name><surname>Peng</surname> <given-names>M</given-names></name><name><surname>Collins</surname> <given-names>R</given-names></name><name><surname>Grove</surname> <given-names>J</given-names></name><name><surname>Klei</surname> <given-names>L</given-names></name><name><surname>Stevens</surname> <given-names>C</given-names></name><name><surname>Reichert</surname> <given-names>J</given-names></name><name><surname>Mulhern</surname> <given-names>MS</given-names></name><name><surname>Artomov</surname> <given-names>M</given-names></name><name><surname>Gerges</surname> <given-names>S</given-names></name><name><surname>Sheppard</surname> <given-names>B</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Bhaduri</surname> <given-names>A</given-names></name><name><surname>Norman</surname> <given-names>U</given-names></name><name><surname>Brand</surname> <given-names>H</given-names></name><name><surname>Schwartz</surname> <given-names>G</given-names></name><name><surname>Nguyen</surname> <given-names>R</given-names></name><name><surname>Guerrero</surname> <given-names>EE</given-names></name><name><surname>Dias</surname> <given-names>C</given-names></name><name><surname>Betancur</surname> <given-names>C</given-names></name><name><surname>Cook</surname> <given-names>EH</given-names></name><name><surname>Gallagher</surname> <given-names>L</given-names></name><name><surname>Gill</surname> <given-names>M</given-names></name><name><surname>Sutcliffe</surname> <given-names>JS</given-names></name><name><surname>Thurm</surname> <given-names>A</given-names></name><name><surname>Zwick</surname> <given-names>ME</given-names></name><name><surname>Børglum</surname> <given-names>AD</given-names></name><name><surname>State</surname> <given-names>MW</given-names></name><name><surname>Cicek</surname> <given-names>AE</given-names></name><name><surname>Talkowski</surname> <given-names>ME</given-names></name><name><surname>Cutler</surname> <given-names>DJ</given-names></name><name><surname>Devlin</surname> <given-names>B</given-names></name><name><surname>Sanders</surname> <given-names>SJ</given-names></name><name><surname>Roeder</surname> <given-names>K</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Buxbaum</surname> <given-names>JD</given-names></name><collab>Autism Sequencing Consortium</collab><collab>iPSYCH-Broad Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Large-Scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism</article-title><source>Cell</source><volume>180</volume><fpage>568</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.12.036</pub-id><pub-id pub-id-type="pmid">31981491</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savas</surname> <given-names>JN</given-names></name><name><surname>De Wit</surname> <given-names>J</given-names></name><name><surname>Comoletti</surname> <given-names>D</given-names></name><name><surname>Zemla</surname> <given-names>R</given-names></name><name><surname>Ghosh</surname> <given-names>A</given-names></name><name><surname>Yates</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ecto-Fc MS identifies ligand-receptor interactions through extracellular domain fc fusion protein baits and shotgun proteomic analysis</article-title><source>Nature Protocols</source><volume>9</volume><fpage>2061</fpage><lpage>2074</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.140</pub-id><pub-id pub-id-type="pmid">25101821</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname> <given-names>LA</given-names></name><name><surname>Hall</surname> <given-names>BJ</given-names></name><name><surname>Patrick</surname> <given-names>GN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Activity-dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway</article-title><source>Journal of Neuroscience</source><volume>30</volume><fpage>16718</fpage><lpage>16729</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3686-10.2010</pub-id><pub-id pub-id-type="pmid">21148011</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sia</surname> <given-names>GM</given-names></name><name><surname>Clem</surname> <given-names>RL</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The human language-associated gene SRPX2 regulates synapse formation and vocalization in mice</article-title><source>Science</source><volume>342</volume><fpage>987</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1126/science.1245079</pub-id><pub-id pub-id-type="pmid">24179158</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigoillot</surname> <given-names>SM</given-names></name><name><surname>Iyer</surname> <given-names>K</given-names></name><name><surname>Binda</surname> <given-names>F</given-names></name><name><surname>González-Calvo</surname> <given-names>I</given-names></name><name><surname>Talleur</surname> <given-names>M</given-names></name><name><surname>Vodjdani</surname> <given-names>G</given-names></name><name><surname>Isope</surname> <given-names>P</given-names></name><name><surname>Selimi</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The secreted protein C1QL1 and its receptor BAI3 control the synaptic connectivity of excitatory inputs converging on cerebellar purkinje cells</article-title><source>Cell Reports</source><volume>10</volume><fpage>820</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.01.034</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotelo</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cellular and genetic regulation of the development of the cerebellar system</article-title><source>Progress in Neurobiology</source><volume>72</volume><fpage>295</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2004.03.004</pub-id><pub-id pub-id-type="pmid">15157725</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname> <given-names>B</given-names></name><name><surname>Allen</surname> <given-names>NJ</given-names></name><name><surname>Vazquez</surname> <given-names>LE</given-names></name><name><surname>Howell</surname> <given-names>GR</given-names></name><name><surname>Christopherson</surname> <given-names>KS</given-names></name><name><surname>Nouri</surname> <given-names>N</given-names></name><name><surname>Micheva</surname> <given-names>KD</given-names></name><name><surname>Mehalow</surname> <given-names>AK</given-names></name><name><surname>Huberman</surname> <given-names>AD</given-names></name><name><surname>Stafford</surname> <given-names>B</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name><name><surname>Litke</surname> <given-names>AM</given-names></name><name><surname>Lambris</surname> <given-names>JD</given-names></name><name><surname>Smith</surname> <given-names>SJ</given-names></name><name><surname>John</surname> <given-names>SW</given-names></name><name><surname>Barres</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The classical complement cascade mediates CNS synapse elimination</article-title><source>Cell</source><volume>131</volume><fpage>1164</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.10.036</pub-id><pub-id pub-id-type="pmid">18083105</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoodley</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The cerebellum and neurodevelopmental disorders</article-title><source>The Cerebellum</source><volume>15</volume><fpage>34</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s12311-015-0715-3</pub-id><pub-id pub-id-type="pmid">26298473</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoodley</surname> <given-names>CJ</given-names></name><name><surname>D'Mello</surname> <given-names>AM</given-names></name><name><surname>Ellegood</surname> <given-names>J</given-names></name><name><surname>Jakkamsetti</surname> <given-names>V</given-names></name><name><surname>Liu</surname> <given-names>P</given-names></name><name><surname>Nebel</surname> <given-names>MB</given-names></name><name><surname>Gibson</surname> <given-names>JM</given-names></name><name><surname>Kelly</surname> <given-names>E</given-names></name><name><surname>Meng</surname> <given-names>F</given-names></name><name><surname>Cano</surname> <given-names>CA</given-names></name><name><surname>Pascual</surname> <given-names>JM</given-names></name><name><surname>Mostofsky</surname> <given-names>SH</given-names></name><name><surname>Lerch</surname> <given-names>JP</given-names></name><name><surname>Tsai</surname> <given-names>PT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Author correction: altered cerebellar connectivity in autism and cerebellar-mediated rescue of autism-related behaviors in mice</article-title><source>Nature Neuroscience</source><volume>21</volume><elocation-id>1016</elocation-id><pub-id pub-id-type="doi">10.1038/s41593-018-0096-2</pub-id><pub-id pub-id-type="pmid">29549317</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suvrathan</surname> <given-names>A</given-names></name><name><surname>Payne</surname> <given-names>HL</given-names></name><name><surname>Raymond</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Timing rules for synaptic plasticity matched to behavioral function</article-title><source>Neuron</source><volume>92</volume><fpage>959</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.10.022</pub-id><pub-id pub-id-type="pmid">27839999</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabata</surname> <given-names>T</given-names></name><name><surname>Sawada</surname> <given-names>S</given-names></name><name><surname>Araki</surname> <given-names>K</given-names></name><name><surname>Bono</surname> <given-names>Y</given-names></name><name><surname>Furuya</surname> <given-names>S</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A reliable method for culture of dissociated mouse cerebellar cells enriched for purkinje neurons</article-title><source>Journal of Neuroscience Methods</source><volume>104</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/S0165-0270(00)00323-X</pub-id><pub-id pub-id-type="pmid">11163410</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname> <given-names>HC</given-names></name><name><surname>Schuman</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction</article-title><source>Nature Reviews Neuroscience</source><volume>9</volume><fpage>826</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/nrn2499</pub-id><pub-id pub-id-type="pmid">18931696</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>WY</given-names></name><name><surname>Martin</surname> <given-names>F</given-names></name><name><surname>Grant</surname> <given-names>D</given-names></name><name><surname>Solloway</surname> <given-names>M</given-names></name><name><surname>Parker</surname> <given-names>L</given-names></name><name><surname>Ye</surname> <given-names>W</given-names></name><name><surname>Forrest</surname> <given-names>W</given-names></name><name><surname>Ghilardi</surname> <given-names>N</given-names></name><name><surname>Oravecz</surname> <given-names>T</given-names></name><name><surname>Platt</surname> <given-names>KA</given-names></name><name><surname>Rice</surname> <given-names>DS</given-names></name><name><surname>Hansen</surname> <given-names>GM</given-names></name><name><surname>Abuin</surname> <given-names>A</given-names></name><name><surname>Eberhart</surname> <given-names>DE</given-names></name><name><surname>Godowski</surname> <given-names>P</given-names></name><name><surname>Holt</surname> <given-names>KH</given-names></name><name><surname>Peterson</surname> <given-names>A</given-names></name><name><surname>Zambrowicz</surname> <given-names>BP</given-names></name><name><surname>de Sauvage</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A mouse knockout library for secreted and transmembrane proteins</article-title><source>Nature Biotechnology</source><volume>28</volume><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1038/nbt.1644</pub-id><pub-id pub-id-type="pmid">20562862</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thouvenot</surname> <given-names>E</given-names></name><name><surname>Urbach</surname> <given-names>S</given-names></name><name><surname>Dantec</surname> <given-names>C</given-names></name><name><surname>Poncet</surname> <given-names>J</given-names></name><name><surname>Séveno</surname> <given-names>M</given-names></name><name><surname>Demettre</surname> <given-names>E</given-names></name><name><surname>Jouin</surname> <given-names>P</given-names></name><name><surname>Touchon</surname> <given-names>J</given-names></name><name><surname>Bockaert</surname> <given-names>J</given-names></name><name><surname>Marin</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid</article-title><source>Journal of Proteome Research</source><volume>7</volume><fpage>4409</fpage><lpage>4421</lpage><pub-id pub-id-type="doi">10.1021/pr8003858</pub-id><pub-id pub-id-type="pmid">18774838</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Titley</surname> <given-names>HK</given-names></name><name><surname>Kislin</surname> <given-names>M</given-names></name><name><surname>Simmons</surname> <given-names>DH</given-names></name><name><surname>Wang</surname> <given-names>SS</given-names></name><name><surname>Hansel</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Complex spike clusters and false-positive rejection in a cerebellar supervised learning rule</article-title><source>The Journal of Physiology</source><volume>597</volume><fpage>4387</fpage><lpage>4406</lpage><pub-id pub-id-type="doi">10.1113/JP278502</pub-id><pub-id pub-id-type="pmid">31297821</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname> <given-names>PT</given-names></name><name><surname>Hull</surname> <given-names>C</given-names></name><name><surname>Chu</surname> <given-names>Y</given-names></name><name><surname>Greene-Colozzi</surname> <given-names>E</given-names></name><name><surname>Sadowski</surname> <given-names>AR</given-names></name><name><surname>Leech</surname> <given-names>JM</given-names></name><name><surname>Steinberg</surname> <given-names>J</given-names></name><name><surname>Crawley</surname> <given-names>JN</given-names></name><name><surname>Regehr</surname> <given-names>WG</given-names></name><name><surname>Sahin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Autistic-like behaviour and cerebellar dysfunction in purkinje cell Tsc1 mutant mice</article-title><source>Nature</source><volume>488</volume><fpage>647</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1038/nature11310</pub-id><pub-id pub-id-type="pmid">22763451</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uemura</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>S-J</given-names></name><name><surname>Yasumura</surname> <given-names>M</given-names></name><name><surname>Takeuchi</surname> <given-names>T</given-names></name><name><surname>Yoshida</surname> <given-names>T</given-names></name><name><surname>Ra</surname> <given-names>M</given-names></name><name><surname>Taguchi</surname> <given-names>R</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Mishina</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Trans-Synaptic interaction of GluRδ2 and neurexin through Cbln1 mediates synapse formation in the cerebellum</article-title><source>Cell</source><volume>141</volume><fpage>1068</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.04.035</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valera</surname> <given-names>AM</given-names></name><name><surname>Doussau</surname> <given-names>F</given-names></name><name><surname>Poulain</surname> <given-names>B</given-names></name><name><surname>Barbour</surname> <given-names>B</given-names></name><name><surname>Isope</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Adaptation of granule cell to purkinje cell synapses to high-frequency transmission</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>3267</fpage><lpage>3280</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3175-11.2012</pub-id><pub-id pub-id-type="pmid">22378898</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>SS</given-names></name><name><surname>Kloth</surname> <given-names>AD</given-names></name><name><surname>Badura</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The cerebellum, sensitive periods, and autism</article-title><source>Neuron</source><volume>83</volume><fpage>518</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.016</pub-id><pub-id pub-id-type="pmid">25102558</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname> <given-names>J</given-names></name><name><surname>Polo</surname> <given-names>S</given-names></name><name><surname>Maspero</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>HECT E3 ligases: a tale with multiple facets</article-title><source>Frontiers in Physiology</source><volume>10</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3389/fphys.2019.00370</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widagdo</surname> <given-names>J</given-names></name><name><surname>Chai</surname> <given-names>YJ</given-names></name><name><surname>Ridder</surname> <given-names>MC</given-names></name><name><surname>Chau</surname> <given-names>YQ</given-names></name><name><surname>Johnson</surname> <given-names>RC</given-names></name><name><surname>Sah</surname> <given-names>P</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name><name><surname>Anggono</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Activity-Dependent ubiquitination of GluA1 and GluA2 regulates AMPA receptor intracellular sorting and degradation</article-title><source>Cell Reports</source><volume>10</volume><fpage>783</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.01.015</pub-id><pub-id pub-id-type="pmid">25660027</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widagdo</surname> <given-names>J</given-names></name><name><surname>Guntupalli</surname> <given-names>S</given-names></name><name><surname>Jang</surname> <given-names>SE</given-names></name><name><surname>Anggono</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulation of AMPA receptor trafficking by protein ubiquitination</article-title><source>Frontiers in Molecular Neuroscience</source><volume>10</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.3389/fnmol.2017.00347</pub-id><pub-id pub-id-type="pmid">29123470</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>J</given-names></name><name><surname>Chung</surname> <given-names>HJ</given-names></name><name><surname>Wihler</surname> <given-names>C</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name><name><surname>Linden</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cerebellar Long-Term depression requires PKC-Regulated interactions between GluR2/3 and PDZ Domain–Containing Proteins</article-title><source>Neuron</source><volume>28</volume><fpage>499</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)00128-8</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>HM</given-names></name><name><surname>Wenthold</surname> <given-names>RJ</given-names></name><name><surname>Petralia</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Glutamate receptor targeting to synaptic populations on purkinje cells is developmentally regulated</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>5517</fpage><lpage>5528</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-14-05517.1998</pub-id><pub-id pub-id-type="pmid">9651232</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>H</given-names></name><name><surname>Meissner</surname> <given-names>LE</given-names></name><name><surname>Byrnes</surname> <given-names>C</given-names></name><name><surname>Tuymetova</surname> <given-names>G</given-names></name><name><surname>Tifft</surname> <given-names>CJ</given-names></name><name><surname>Proia</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The complement regulator Susd4 influences Nervous-System function and neuronal morphology in mice</article-title><source>iScience</source><volume>23</volume><elocation-id>100957</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.100957</pub-id><pub-id pub-id-type="pmid">32179479</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65712.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Carey</surname><given-names>Megan R</given-names></name><role>Reviewing Editor</role><aff><institution>Champalimaud Foundation</institution><country>Portugal</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/10.1101/859587">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/859587v2.full">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This is a very interesting paper that demonstrates the involvement of a specific protein degradation pathway in synaptic plasticity in the cerebellum. The authors show that SUSD4 is expressed throughout the brain and is abundant in cerebellar dendrites and spines. Mice with SUSD4 deletion have motor coordination and learning deficits, along with impaired LTD induction. This study provides novel insight into the uncharacterized role of SUSD4 and provides a detailed and well-performed analysis of the SUSD4 loss of function phenotype in the cerebellar circuit.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;SUSD4 controls GLUA2 degradation, synaptic plasticity and motor learning&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Megan Carey as Reviewing Editor and Gary Westbrook as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions:</p><p>The paper is broad in scope, which was seen as both a strength and a weakness. In particular, the reviewers agreed that the cerebellar physiology was strong, but the proposed cellular/ molecular mechanism of degradation rather than internalization was intriguing, but not fully developed. There was also concern raised about the ease with which the authors move from a brain-wide SUSD4 expression pattern, to a focus exclusively on Purkinje cell physiology, and then to attempting to link that to behaviors that are cerebellum-dependent, but not cerebellum-specific. The Reviewers and Editors agreed that the paper could be suitable for <italic>eLife</italic> if the technical issues raised by the reviewers were addressed, as well as conclusions tempered regarding mechanism and cerebellar specificity/ behavior.</p><p>1) Address the points of reviewer 1 regarding electrophysiological experiments.</p><p>2) The proposed mechanism is interesting, but preliminary. The authors should tone down significantly their mechanistic conclusions, and present the data factually, without trying to make a bigger &quot;story&quot; out of them than it is possible at this point.</p><p>3) In addition, please address the technical points raised regarding mechanism, particularly those of reviewer 3 regarding the IP in Figure 5.</p><p>4) The authors have not demonstrated clear links between the physiological results and the behavioral deficits. Especially within the context of brain-wide expression patterns for SUSD4, the authors should directly address this limitation and avoid implied causality.</p><p>5) <italic>eLife</italic> policy for titles states: Authors should avoid acronyms in the title:</p><p>Titles of <italic>eLife</italic> research papers should avoid unfamiliar abbreviations or acronyms, or authors should spell out in full or provide a brief explanation for any acronyms. Please revise your title with this advice in mind.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Figure 3A-C can be moved to supplementary, it's negative findings that are not directly pertaining to the conclusions.</p><p>The authors often use term like &quot;could&quot;, &quot;might&quot; which casts a bit of uncertainty on their confidence on their conclusions. It would be better to either provide data that either support or dismiss a model, and state the conclusions in that manner.</p><p>GLUA2 is not the correct terminology, is should be GluA2</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65712.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>The paper is broad in scope, which was seen as both a strength and a weakness. In particular, the reviewers agreed that the cerebellar physiology was strong, but the proposed cellular/ molecular mechanism of degradation rather than internalization was intriguing, but not fully developed. There was also concern raised about the ease with which the authors move from a brain-wide SUSD4 expression pattern, to a focus exclusively on Purkinje cell physiology, and then to attempting to link that to behaviors that are cerebellum-dependent, but not cerebellum-specific. The Reviewers and Editors agreed that the paper could be suitable for eLife if the technical issues raised by the reviewers were addressed, as well as conclusions tempered regarding mechanism and cerebellar specificity/ behavior.</p><p>1) Address the points of reviewer 1 regarding electrophysiological experiments.</p></disp-quote><p>We have addressed the points of reviewer 1 regarding electrophysiological experiments: 1) by modifying the text in the Results section regarding the LTP induction; 2) By adding an analysis of the complex spike waveform during LTD induction in current clamp mode (Figure 3—figure supplement 1).</p><disp-quote content-type="editor-comment"><p>2) The proposed mechanism is interesting, but preliminary. The authors should tone down significantly their mechanistic conclusions, and present the data factually, without trying to make a bigger &quot;story&quot; out of them than it is possible at this point.</p></disp-quote><p>We have changed the text to address this concern, in particular the end of the Abstract, Introduction, the Results section and the Discussion.</p><disp-quote content-type="editor-comment"><p>3) In addition, please address the technical points raised regarding mechanism, particularly those of reviewer 3 regarding the IP in Figure 5.</p></disp-quote><p>We have modified Figure 5D to show the amount of co-immunoprecipitated GluA2 normalized to the input GluA2 and relative to the amount of immunoprecipitated HA-tagged SUSD4 construct. We have also added the quantifications of the inputs in Figure 5—figure supplement 2.</p><p>We have added a new experiment (Figure 4—figure supplement 2) that provides the control requested by reviewer 3 for non-specific binding of overexpressed membrane proteins. We have performed the reverse co-immunoprecipitation experiment using SEP-GluA2 as a bait and probed for HA-SUSD4 or control PVRL3α in the affinity-purified extracts. While both HA-SUSD4 and PVRL3α are readily detected in the inputs, only HA-SUSD4 is detected in the immunopurified extracts confirming the specific interaction between SEP-GluA2 and HA-SUSD4 in transfected HEK293 cells.</p><disp-quote content-type="editor-comment"><p>4) The authors have not demonstrated clear links between the physiological results and the behavioral deficits. Especially within the context of brain-wide expression patterns for SUSD4, the authors should directly address this limitation and avoid implied causality.</p></disp-quote><p>We are sorry if we have unintentionally conveyed the idea that the behavioral phenotype is a direct result of synaptic deficits in Purkinje cells. This can indeed only be demonstrated using a conditional invalidation of <italic>Susd4</italic> in Purkinje cells. We have modified the text accordingly to avoid implied causality. We have also directly addressed this limitation in the Discussion.</p><disp-quote content-type="editor-comment"><p>5) eLife policy for titles states: Authors should avoid acronyms in the title:</p><p>Titles of eLife research papers should avoid unfamiliar abbreviations or acronyms, or authors should spell out in full or provide a brief explanation for any acronyms. Please revise your title with this advice in mind.</p></disp-quote><p>We have modified the title to remove abbreviations.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Figure 3A-C can be moved to supplementary, it's negative findings that are not directly pertaining to the conclusions.</p></disp-quote><p>We have moved Figure 3A and 3B to the supplementary. We have kept Figure 3C in the main, since while the results are negative, we think that they are important to properly interpret the electrophysiology data.</p><disp-quote content-type="editor-comment"><p>The authors often use term like &quot;could&quot;, &quot;might&quot; which casts a bit of uncertainty on their confidence on their conclusions. It would be better to either provide data that either support or dismiss a model, and state the conclusions in that manner.</p></disp-quote><p>We have changed the text accordingly.</p><disp-quote content-type="editor-comment"><p>GLUA2 is not the correct terminology, is should be GluA2</p></disp-quote><p>As requested, we have corrected the text and are using GluA2 and GluD2 when referring to glutamate receptor subunits. For the rest of the genes/proteins referred to in this study, we have kept the format defined by the International Committee on Standardized Genetic Nomenclature for Mice (http://www.informatics.jax.org/mgihome/nomen/gene.shtml#gene_sym): “Protein symbols use all uppercase letters.”</p></body></sub-article></article>